Home Cart Sign in  
Chemical Structure| 56974-61-9 Chemical Structure| 56974-61-9

Structure of Gabexate Mesylate
CAS No.: 56974-61-9

Chemical Structure| 56974-61-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Gabexate mesylate could inhibit trypsin, plasmin, plasma kallikrein and thrombin with IC50s of 9.4 μM, 30 μM, 41 μM and 110 μM. It has certain anticoagulant effect.

Synonyms: FOY; Gabexate (mesylate)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Gabexate Mesylate

CAS No. :56974-61-9
Formula : C17H27N3O7S
M.W : 417.48
SMILES Code : O=C(OCC)C1=CC=C(OC(CCCCCNC(N)=N)=O)C=C1.CS(=O)(O)=O
Synonyms :
FOY; Gabexate (mesylate)
MDL No. :MFCD00210299
InChI Key :DNTNDFLIKUKKOC-UHFFFAOYSA-N
Pubchem ID :6604561

Safety of Gabexate Mesylate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Female Swiss Webster mice Acute hemorrhagic pancreatitis induced by choline-deficient, ethionine-supplemented (CDE) diet Subcutaneous injection 100 mg/kg Every 6 hours for 66 hours (12 injections total) Prophylactic administration of Gabexate significantly improved survival (from 37% to 85%) and reduced the increases in serum amylase concentration and pancreatic activated trypsin. Histological examination showed that necrosis and inflammation were essentially absent. However, when Gabexate was given after pancreatitis had already been induced (therapeutic regimen), its protective effects were almost completely lost. PMC423760
BALB/c mice Chronic asthma mouse model Intraperitoneal injection 20mg/kg Once a week for five weeks To evaluate the effects of Gabexate on airway hyperresponsiveness, inflammation, and remodeling in a chronic asthma model. Results showed that Gabexate significantly reduced airway hyperresponsiveness, inflammatory cell infiltration, and Th2 cytokine levels. PMC4142284
B6 mice EG.7 tumor transplantation model Subcutaneous injection 200 μg/mouse Once a week for 3 weeks To evaluate the enhancing effect of Gabexate mesilate as an HMGB1 inhibitor on peptide vaccine-induced CTL proliferation. Results showed that Gabexate mesilate significantly enhanced OVA 257–264-induced OT-1 CD8 T-cell proliferation. PMC5198958

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00835705 - Completed - -
NCT00703755 Patients With Metabolic Syndro... More >>me Less << Phase 2 Completed - -
NCT00035256 Osteoporosis, Postmenopausal Phase 4 Completed - United States, Illinois ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Maywood, Illinois, United States United States, Oregon For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Portland, Oregon, United States Canada, Ontario For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Kitchener, Ontario, Canada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician London, Ontario, Canada Canada, Quebec For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Sainte -Foy, Quebec, Canada Less <<
NCT00549757 Type 2 Diabetes Mellitus ... More >> Cardiovascular Disease Less << Phase 3 Terminated(Lack of benefit and... More >> safety concern) Less << - -
NCT01354145 Knee Osteoarthritis Phase 3 Completed - Canada, Quebec ... More >> Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM) Montreal, Quebec, Canada, J1H-5N4 Institut de Rhumatologie de Montréal Montréal, Quebec, Canada, H2L-1S6 Groupe de Recherche en rhumatologie et maladies osseoues Québec, Quebec, Canada, G1V-3M7 Centre de Rhumatologie St. Louis Sante Foi, Quebec, Canada, G1W-4R4 Centre de Recherche musculo-squellettique Trois-Rivières, Quebec, Canada, G8A-1Y2 Less <<
NCT01354145 - Completed - -
NCT00410280 Asthma Phase 2 Completed - Canada, British Columbia ... More >> University of British Columbia Vancouver, British Columbia, Canada, V5Z 1M9 University of British Columbia Vancouver, British Columbia, Canada, V5Z 3J5 Canada, Ontario McMaster University Medical Hamilton, Ontario, Canada, L8N 3Z5 Canada, Quebec Hopital Laval Ste-Foy, Quebec, Canada, G1V 4G5 Less <<
NCT00410280 - Completed - -
NCT01405963 Asthma Phase 1 Completed - Canada, Alberta ... More >> Research Site Calgary, Alberta, Canada, T2N 4Z6 Canada, British Columbia Research Site Vancouver, British Columbia, Canada, V5Z 1M9 Canada, Ontario Research Site Hamilton, Ontario, Canada, L8N 3Z5 Canada, Quebec Research Site Sainte-Foy, Quebec, Canada, G1V 4G5 Canada, Saskatchewan Research Site Saskatoon, Saskatchewan, Canada, S7N 0W8 Less <<
NCT00289952 HIV Infections Phase 2 Unknown December 2008 Canada, British Columbia ... More >> BC St-Paul's Hospital/Immunodeficiency Clinic Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Ontario Ottawa Health Research Institute/Immunodeficiency Clinic Ottawa, Ontario, Canada, K1H 8L6 Canada, Quebec Actuel Medical Clinic Montreal, Quebec, Canada, H2L 4P9 Quartier Latin Medical Clinic Montreal, Quebec, Canada, H2L 5B1 Montreal Chest Institute/Immunodeficiency Clinic Montreal, Quebec, Canada, H2X 2P4 CHUL Ste-Foy Ste-Foy, Quebec, Canada, G1V 4G2 Less <<
NCT00232999 Asthma Phase 2 Completed - Canada, Ontario ... More >> Department of Medicine, McMaster University Hamilton, Ontario, Canada, L8N 3Z5 Canada, Quebec Centre de cardiology et de pneumologie de l'Universite Laval Sainte-Foy (Quebec City), Quebec, Canada, G1V 4G5 Canada, Saskatchewan University of Saskatchewan Saskatoon, Saskatchewan, Canada, S7N 0W8 Less <<
NCT00110682 Keratosis Act... More >>inic Keratosis Less << Phase 4 Completed - Canada, British Columbia ... More >> DermResearch @ 888 Inc Vancouver, British Columbia, Canada, V4C 6X4 Canada, Ontario Windsor Clinical Research Windsor, Ontario, Canada Canada, Quebec Centre de Recherche Dermatologique, CRDQ Sainte-Foy, Quebec, Canada, G1V 4X7 Less <<
NCT00974428 Knee Osteoarthritis Phase 2 Phase 3 Withdrawn - Canada, Quebec ... More >> Institut de Rhumatologie de Montréal Montreal, Quebec, Canada, H2L 1S6 Centre de Rhumatologie St-Louis Sainte-foy, Quebec, Canada, G1W 4R4 Centre de Recherche Musculo-Squelettique Trois-Rivieres, Quebec, Canada, G8Z 1Y2 Canada Groupe de Recherche en Rhumatologie et maladies osseuses Quebec, Canada, G1V 3M7 Less <<
NCT02509481 Malaria Lymph... More >>atic Filariasis Less << Phase 2 Phase 3 Completed - United States, Colorado ... More >> Colorado State University Fort Collins, Colorado, United States, 80523 Burkina Faso Institut de Recherche en Sciences de la Santé Bobo Dioulasso, Houet, Burkina Faso, 10400-000 Less <<
NCT00264966 Asthma Phase 1 Phase 2 Completed - Canada, Ontario ... More >> McMaster University Hamilton, Ontario, Canada, L8N 3Z5 Canada, Quebec Hopital Laval Ste-Foy, Quebec, Canada, G1V 4G5 Canada, Saskatchewan Saskatoon Hospital Saskatoon, Saskatchewan, Canada, S7N 0W8 Less <<
NCT00828321 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Montreal, Quebec, Canada, H2X 2H9 Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT03468634 - Not yet recruiting July 2019 -
NCT00549757 - Terminated(Lack of benefit and... More >> safety concern) Less << - -
NCT00604539 Synovitis Ost... More >>eoarthritis Joint Diseases Muskuloskeletal Diseases Less << Phase 3 Completed - Canada, Quebec ... More >> Inst. De Rhumatologie Montréal, Quebec, Canada, H2L 1S6 Groupe de recherche en rhumatologie et maladies osseuses Ste-Foy, Quebec, Canada, G1V 3M7 Centre de rhumatologie St-Louis Ste-Foy, Quebec, Canada, G1W 4R4 Centre de recherche musculo-squelettique Trois-Rivieres, Quebec, Canada, G8A 1Y2 Less <<
NCT00829452 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Montreal, Quebec, Canada, H2X 2H9 Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00828321 - Completed - -
NCT00829452 - Completed - -
NCT00829530 - Completed - -
NCT00834249 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Montreal, Quebec, Canada, H3X 2H9 Anapharm Inc. Sainte-Foy, Quebec, Canada, GIV2K8 Less <<
NCT00399594 Heart Failure, Congestive ... More >> Cardiac Pacing, Artificial Defibrillators Less << Phase 2 Phase 3 Completed - Canada, Alberta ... More >> Foothills Hospital Calgary, Alberta, Canada, T2N4N1 Canada, Ontario London Health Sciences London, Ontario, Canada Canada, Quebec Quebec Heart Institute Ste-Foy, Quebec, Canada, G1V4G5 Less <<
NCT00834249 - Completed - -
NCT00834964 - Completed - -
NCT00829530 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Montreal, Quebec, Canada, H2X 2H9 Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00834977 - Completed - -
NCT00485576 Allergic Asthma Phase 2 Completed - Canada, Ontario ... More >> McMaster University Hamilton, Ontario, Canada, L8N 3Z5 Canada, Quebec Hospital Laval Ste-Foy, Quebec, Canada, G1V 4G5 Less <<
NCT00835367 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Montreal, Quebec, Canada, H2X 2H9 SFBC Anapharm Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00834977 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Montreal, Quebec, Canada, H3X H29 SFBC Anapharm Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00834964 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Montreal, Quebec, Canada, H3X 2H9 Anapharm Inc. Sainte-Foy, Quebec, Canada, GIV2K8 Less <<
NCT00928668 Asthma Phase 2 Completed - Canada, British Columbia ... More >> 1222.4.103 UBC - Respiratory Medicine Vancouver, British Columbia, Canada Canada, Ontario 1222.4.104 Department of Medicine, Health Sciences Centre Hamilton, Ontario, Canada Canada, Quebec 1222.4.101 2725 Chemin Ste Foy Sainte-Foy, Quebec, Canada Canada, Saskatchewan 1222.4.102 Saskatoon, Saskatchewan, Canada Less <<
NCT00835367 - Completed - -
NCT01528761 Physical Activity Not Applicable Completed - United States, North Carolina ... More >> Wake Forest School of Medicine Winston-Salem, North Carolina, United States, 27157 Less <<
NCT02904629 Sex Unprotect... More >>ed Sex Contraception Alcohol Use Drug Use Pregnancy Less << Not Applicable Enrolling by invitation August 2021 United States, Arizona ... More >> Johns Hopkins Center for American Indian Health Whiteriver, Arizona, United States, 85941 Less <<
NCT01065987 Healthy Phase 1 Completed - Canada ... More >> Anapharm Inc. Sainte-Foy (Quebec), Canada Less <<
NCT01373138 Healthy Phase 1 Completed - Canada ... More >> SFBC Anapharm Sainte-Foy (Quebec), Canada, G1V 2K8 Less <<
NCT00928668 - Completed - -
NCT01146028 Healthy Phase 1 Completed - Canada ... More >> Anapharm Inc. Sainte-Foy (Quebec), Canada Less <<
NCT01066767 Healthy Phase 1 Completed - Canada ... More >> Anapharm Inc., Sainte-Foy Quebec, Canada, G1V 2K8 Less <<
NCT01512485 Healthy Phase 1 Completed - Canada ... More >> Anapharm Sainte-Foy (Quebec), Canada Less <<
NCT01066754 Healthy Phase 1 Completed - Canada ... More >> Anapharm Inc., Sainte-Foy Quebec, Canada, G1V 2K8 Less <<
NCT00157729 Diabetes Mellitus Type 2 ... More >> Hypertension Metabolic Syndrome Less << Phase 2 Completed - Canada, Quebec ... More >> Centre Hospitalier Université Laval Sainte-Foy, Quebec, Canada, G1V 4G2 Less <<
NCT01506713 Fasting Phase 1 Completed - Canada ... More >> Anapharm Sainte-Foy (Quebec), Canada Less <<
NCT00169819 Coronary Artery Disease ... More >> Ischemia Less << Phase 4 Completed - Canada, Quebec ... More >> Laval Hospital Research Center Sainte-Foy, Quebec, Canada, G1V 4G5 Less <<
NCT00169871 - Completed - Canada, Quebec ... More >> Lipid Research Center, CHUL Research Center Sainte-Foy, Quebec, Canada, G1V 4G2 Less <<
NCT00317148 Hot Flashes Phase 2 Phase 3 Completed - Canada, Quebec ... More >> Clinique des Traitements Hormonaux Sainte-Foy, Quebec, Canada, G1V 4G2 Less <<
NCT00248989 Skin Aging Qu... More >>ality of Life Less << Phase 3 Completed - Canada, Quebec ... More >> Clinique des Traitements Hormonaux- CHUL Research Center Sainte-Foy, Quebec, Canada, G1V 4G2 Less <<
NCT00652704 To Determine Bioequivalence Un... More >>der Fed Conditions Less << Phase 1 Completed - Canada, Quebec ... More >> Anapharm, Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00653120 To Determine Bioequivalence Un... More >>der Fasting Conditions Less << Phase 2 Completed - Canada, Quebec ... More >> SFBC Anapharm Sainte- Foy, Quebec, Canada, G1V2K8 Less <<
NCT00652873 To Determine Bioequivalence Un... More >>der Fed Conditions Less << Phase 1 Completed - Canada, Quebec ... More >> Anapharm, Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00829894 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00653380 To Determine Bioequivalence Un... More >>der Fasting Conditions Less << Phase 1 Completed - Canada, Quebec ... More >> Anapharm, Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00830349 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00834561 - Completed - -
NCT00834561 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00653055 To Determine Bioequivalence Un... More >>der Fasting Conditions Less << Phase 1 Completed - Canada, Quebec ... More >> Anapharm, Inc. Sainte-Foy, Quebec, Canada, GiV 2K8 Less <<
NCT00835406 - Completed - -
NCT00835406 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, GIV2K8 Less <<
NCT00652795 To Determine Bioequivalence Un... More >>der Fasting Conditions Less << Phase 1 Completed - Canada, Quebec ... More >> Anapharm Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00835991 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, GIV2K8 Less <<
NCT00835991 - Completed - -
NCT00836004 - Completed - -
NCT00835263 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00836004 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00835705 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00836056 - Completed - -
NCT00836056 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00835263 - Completed - -
NCT00836472 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, GIV2K8 Less <<
NCT00836849 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, GIV2K8 Less <<
NCT00836667 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, GIV2K8 Less <<
NCT00838136 - Completed - -
NCT00838279 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, GIV2K8 Less <<
NCT00836472 - Completed - -
NCT00841659 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada Less <<
NCT00841659 - Completed - -
NCT00841698 - Completed - -
NCT00838136 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, GIV2K8 Less <<
NCT00841698 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada Less <<
NCT00838279 - Completed - -
NCT00849862 Healthy Phase 1 Completed - Canada, Quebec ... More >> SFBC-Anapharm Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00849862 - Completed - -
NCT00849485 - Completed - -
NCT00904943 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00849485 Healthy Phase 1 Completed - Canada, Quebec ... More >> SFBC Anapharm Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00871247 Healthy Phase 1 Completed - Canada, Quebec ... More >> SFBC Anapharm Sainte-Foy, Quebec, Canada, G 1 V 2K8 Less <<
NCT00905164 - Completed - -
NCT00905346 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00904943 - Completed - -
NCT00905567 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00905346 - Completed - -
NCT00905606 - Completed - -
NCT00972855 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00905164 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00870480 Healthy Phase 1 Completed - Canada, Quebec ... More >> SFBC Anapharm Sainte-Foy, Quebec, Canada, G 1 V 2K8 Less <<
NCT01044706 Healthy Phase 1 Completed - Canada, Quebec ... More >> SFBC Anapharm sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00973050 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT01052909 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc Sainte-Foy, Quebec, Canada, GIV 2KB Less <<
NCT00905606 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT01124175 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT00905567 - Completed - -
NCT01149460 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT01124175 - Completed - -
NCT01044706 - Completed - -
NCT01053689 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc Sainte-Foy, Quebec, Canada, GIV 2KB Less <<
NCT01190748 Healthy Phase 1 Completed - Canada, Quebec ... More >> SFBC Anapharm Sainte-Foy, Quebec, Canada, G 1 V 2K8 Less <<
NCT01190761 Healthy Phase 1 Completed - Canada, Quebec ... More >> SFBC Anapharm Sainte-Foy, Quebec, Canada, G 1 V 2K8 Less <<
NCT01282801 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT01149460 - Completed - -
NCT01260896 - Completed - -
NCT01282814 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT01282801 - Completed - -
NCT01260896 Healthy Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada, G1V 2K8 Less <<
NCT01380496 To Determine Bioequivalence Un... More >>der Fed Conditions Less << Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada Less <<
NCT00835445 - Completed - Canada, Quebec ... More >> Hopital Laval Ste-Foy, Quebec, Canada, G1V 4G5 Less <<
NCT01380483 To Determine Bioequivalence Un... More >>der Fasting Conditions Less << Phase 1 Completed - Canada, Quebec ... More >> Anapharm Inc. Sainte-Foy, Quebec, Canada Less <<
NCT01002911 Arrythmias Phase 3 Completed - Canada, Quebec ... More >> Institut universitaire de cardiologie et de pneumologie de Quebec Ste-Foy, Quebec, Canada, G1V 4G5 Less <<
NCT02693093 Chronic Pancreatitis Phase 1 Phase 2 Recruiting August 2020 -
NCT02501577 Intubation; Difficult Not Applicable Unknown October 2015 Germany ... More >> University Regensburg Recruiting Regensburg, Germany, 93051 Contact: Thomas Metterlein, MD    +499419440    thomas.metterlein@ukr.de    Contact: Christoph Plank, MD    +499419440    christoph.plank@ukr.de Less <<
NCT01282814 - Completed - -
NCT01435655 Transthyretin Familial Amyloid... More >> Polyneuropathy Less << Phase 3 Completed - Japan ... More >> Kumamoto University Hospital/Department of Neurology Kumamoto-shi, Kumamoto, Japan, 860-8556 Shinshu University Hospital/Department of Medicine (Neurology and Reumatology) Matsumoto-shi, Nagano, Japan, 390-8621 Less <<
NCT01435655 - Completed - -
NCT01716130 - Completed - United States, California ... More >> Touro University California Vallejo, California, United States, 94592 Less <<
NCT03678246 Obesity Not Applicable Recruiting December 31, 2018 Singapore ... More >> Singapore General Hospital Recruiting Singapore, Singapore, 169608 Contact: Patrick Wong    +65 6326 4220    patrick.wong@singhealth.com.sg    Sub-Investigator: Patrick Wong          Principal Investigator: Wan Yen Lim Less <<
NCT02782156 - Completed - Switzerland ... More >> University Hospital Basel Basel, Switzerland, 4031 Less <<
NCT00887055 - Withdrawn(never started) - Canada, Quebec ... More >> Hopital Laval Ste-Foy, Quebec, Canada, G1V 4G5 Less <<
NCT03663296 Education, Medical Not Applicable Recruiting December 1, 2018 Singapore ... More >> National University Hospital, Singapore Recruiting Singapore, Singapore, 119074 Contact: Ying Wei Yau    +65-6779 5555    ying_wei_yau@nuhs.edu.sg Less <<
NCT03075813 Infection Control ... More >> Surgical Site Infection Less << Not Applicable Recruiting February 2020 United States, North Carolina ... More >> Duke University Health System Recruiting Durham, North Carolina, United States, 27705 Contact: Katherine R Foy, RN    919-668-3833    katherine.foy@duke.edu    Principal Investigator: Deverick Anderson, MD          Sub-Investigator: Arthur Baker, MD Less <<
NCT00630864 Transthyretin-associated Amylo... More >>idosis With Polyneuropathy Less << Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins Hospital Baltimore, Maryland, United States, 21205 France CHU de Bicetre Paris, France Germany Universitatsklinikum Munster, Transplant Hepatology Munster, Germany Italy Centro per lo Studio e la Cura delle Amiloidosi Sistemiche IRCCS - Policlinico San Matteo, Pavia, Italy, 19 - 27100 Less <<
NCT00747019 Health-Related Quality of Life... More >> Physical Activity Physical Function Less << Not Applicable Unknown June 2010 United States, North Carolina ... More >> Wake Forest University School of Medicine Recruiting Winston-Salem, North Carolina, United States, 27127 Contact: Carol Massa-Fanale    336-716-3589    cmassa@wfubmc.edu    Contact: Susan J. Harris    336-713-4244    sjharris@wfubmc.edu    Principal Investigator: Capri G. Foy, PhD, MS Less <<
NCT03247803 Intubation; Difficult or Faile... More >>d Laryngeal Masks Less << Not Applicable Recruiting December 30, 2019 United States, Wisconsin ... More >> University of Wisconsin Hopital and Clinics Recruiting Madison, Wisconsin, United States, 53792 Contact: Richard E Galgon, MD,MS    608-263-8100    galgon@wisc.edu    Principal Investigator: Richard E Galgon, MD,MS Less <<
NCT00694161 - Completed - -
NCT01910714 HIV/AIDS Not Applicable Completed - United States, Maryland ... More >> Johns Hopkins Center for American Indian Health Baltimore, Maryland, United States, 21205 Less <<
NCT00694161 Cardiomyopathy Phase 2 Completed - United States, Georgia ... More >> Emory University School of Medicine Atlanta, Georgia, United States, 30322 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Maryland Johns Hopkins Hospital Baltimore, Maryland, United States, 21205 United States, Massachusetts Harvard Vanguard Medical Associates Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New York Columbia University New York, New York, United States, 10032 Less <<
NCT02710266 Liver Disease Phase 3 Terminated(This study was clos... More >>ed earlier than planned because targeted participant recruitment is not smooth.) Less << - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 03722 Less <<
NCT00630864 - Completed - -
NCT00643227 Pneumonia Phase 3 Completed - -
NCT01358578 - Completed - -
NCT00644449 Bronchitis, Chronic Phase 3 Completed - -
NCT00643734 Pneumonia Phase 3 Completed - -
NCT00631475 Idiopathic Pulmonary Fibrosis Phase 3 Completed - -
NCT01238497 - Active, not recruiting December 2018 -
NCT00645086 Acute Bacterial Exacerbation o... More >>f Chronic Bronchitis (ABECB). Less << Phase 3 Completed - -
NCT00631475 - Completed - -
NCT00662740 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Terminated - -
NCT01272908 Rheumatoid Arthritis Phase 3 Completed - -
NCT00144326 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - Canada, Nova Scotia ... More >> 1796 Summer Street Halifax, Nova Scotia, Canada, B3H 3A7 Canada, Ontario Kingston General Hospital Kingston, Ontario, Canada, K7L 2V6 Respiratory/ Research Lab Toronto, Ontario, Canada, M5T 2S8 Canada, Quebec Montreal Chest Institute of the Royal Victoria Hospital Montreal, Quebec, Canada, H2X 1P4 Hopital Laval Ste-Foy, Quebec, Canada, G1V 4G5 Canada, Saskatchewan Department of Respiratory Medicine Saskatoon, Saskatchewan, Canada, S7N 0W8 Germany Boehringer Ingelheim Investigational Site Berlin, Germany, 13597 Boehringer Ingelheim Investigational Site Berlin, Germany, 14057 Krankenhaus Donaustauf Donaustauf, Germany, 93093 Boehringer Ingelheim Investigational Site Fürth, Germany, 90762 Inamed Research GmbH & Co. KG Gauting, Germany, 82131 Pneumologisches Forschungsinstitut GmbH Großhansdorf, Germany, 22927 Pneumologisches Forschungsinstitut GmbH am Krankenhaus Hamburg, Germany, 20535 Allergomedic Hannover, Germany, 30159 Klinik III für Innere Medizin/ Pneumologie Köln, Germany, 50922 Boehringer Ingelheim Investigational Site Rüdersdorf, Germany, 15562 Spain Hospital Universitario Príncipe de Asturias Alcalá de Henares (Madrid), Spain, 28805 Hospital Clinic i Provincial de Barcelona Barcelona, Spain, 08036 Centro de Asistencia Primaria de Campdevanol Campdevànol (Girona), Spain, 17530 Hospital San Pedro de Alcántara Cáceres, Spain, 10001 Hospital Universitario Reína Sofía Córdoba, Spain, 14004 Hospital General de Elche Elche (Alicante), Spain, 02303 Hospital Ntra. Sra. de Meritxell Escaldes-Engordany, Spain Centro de Asistencia Primaria de la Roca La Roca del Vallés (Barcelona), Spain, 08430 Hospital de la Princesa Madrid, Spain, 28006 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Vírgen de la Victoria Málaga, Spain, 29080 Less <<
NCT01272908 - Completed - -
NCT01291914 Osteoarthritis, Knee Phase 1 Phase 2 Completed - Austria ... More >> Graz, Austria Wien, Austria Canada, British Columbia Penticton, British Columbia, Canada Canada, Ontario Newmarket, Ontario, Canada Toronto, Ontario, Canada Windsor, Ontario, Canada Canada, Quebec Sainte-Foy, Quebec, Canada Spain Santiago de Compostela, A Coruna, Spain Santander, Cantabria, Spain A Coruna, Spain Barcelona, Spain Sevilla, Spain United Kingdom Southampton, United Kingdom Less <<
NCT01268072 - Terminated(Study was completed... More >> with 69 subjects enrolled due to difficult enrolment and adequate biomarker data was avaible with 69 subjects in the study.) Less << - United States, Maryland ... More >> Research Site Baltimore, Maryland, United States, 21201 United States, Massachusetts Research Site Springfield, Massachusetts, United States, 01199 United States, Missouri Research Site St. Louis, Missouri, United States, 63110 United States, New York Research Site Buffalo, New York, United States, 14215 United States, Ohio Research Site Cincinnati, Ohio, United States, 45267 United States, Pennsylvania Research Site Philadelphia, Pennsylvania, United States, 19140 Research Site Pittsburgh, Pennsylvania, United States, 15213 United States, Rhode Island Research Site Providence, Rhode Island, United States, 02903 United States, Texas Research Site Houston, Texas, United States, 77030 Canada, Quebec Research Site Sainte-Foy, Quebec, Canada, G1V 4G5 Less <<
NCT00720499 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - United States, Florida ... More >> 1237.9.00152 Boehringer Ingelheim Investigational Site Clearwater, Florida, United States 1237.9.00155 Boehringer Ingelheim Investigational Site Tampa, Florida, United States United States, Pennsylvania 1237.9.00151 Boehringer Ingelheim Investigational Site Philadelphia, Pennsylvania, United States United States, Texas 1237.9.00154 Boehringer Ingelheim Investigational Site Killeen, Texas, United States United States, Washington 1237.9.00153 Boehringer Ingelheim Investigational Site Spokane, Washington, United States Belgium 1237.9.03253 Boehringer Ingelheim Investigational Site Brussel, Belgium 1237.9.03255 Boehringer Ingelheim Investigational Site Bruxelles, Belgium 1237.9.03254 Boehringer Ingelheim Investigational Site Edegem, Belgium 1237.9.03251 Boehringer Ingelheim Investigational Site Gent, Belgium 1237.9.03252 Boehringer Ingelheim Investigational Site Leuven, Belgium Canada, Ontario 1237.9.00255 Boehringer Ingelheim Investigational Site Mississauga, Ontario, Canada 1237.9.00251 Boehringer Ingelheim Investigational Site Toronto, Ontario, Canada 1237.9.00252 Boehringer Ingelheim Investigational Site Toronto, Ontario, Canada 1237.9.00254 Boehringer Ingelheim Investigational Site Toronto, Ontario, Canada Canada, Quebec 1237.9.00253 Boehringer Ingelheim Investigational Site Ste-Foy, Quebec, Canada Germany 1237.9.04952 Boehringer Ingelheim Investigational Site Berlin, Germany 1237.9.04953 Boehringer Ingelheim Investigational Site Berlin, Germany 1237.9.04954 Boehringer Ingelheim Investigational Site Berlin, Germany 1237.9.04955 Boehringer Ingelheim Investigational Site Bruchsal, Germany 1237.9.04959 Boehringer Ingelheim Investigational Site Gelnhausen, Germany 1237.9.04960 Boehringer Ingelheim Investigational Site Großhansdorf, Germany 1237.9.04958 Boehringer Ingelheim Investigational Site Hamburg, Germany 1237.9.04951 Boehringer Ingelheim Investigational Site Tübingen, Germany 1237.9.04956 Boehringer Ingelheim Investigational Site Wiesloch, Germany Less <<
NCT00769119 - Completed - -
NCT00769119 Bronchiectasis Phase 2 Completed - Canada, Quebec ... More >> Research Site Chemin Sainte-Foy, Quebec, Canada Canada Research Site Calgary, Canada Research Site Montreal, Canada Research Site Ontario, Canada Research Site Vancouver, Canada United Kingdom Research Site Birmingham, United Kingdom Research Site Cambridge, United Kingdom Research Site London, United Kingdom Research Site New Castle, United Kingdom Less <<
NCT01274507 Asthma Pulmon... More >>ary Disease, Chronic Obstructive Less << Early Phase 1 Completed - -
NCT01327053 - Completed - -
NCT00720499 - Completed - -
NCT01307423 - Completed - -
NCT01307423 Psoriatic Arthritis Phase 3 Completed - -
NCT00754065 Contraception Phase 3 Completed - -
NCT00754065 - Completed - -
NCT01327053 Basal Cell Carcinoma Phase 2 Completed - -
NCT01350804 Rheumatoid Arthritis Phase 3 Completed - -
NCT00266032 - Completed - -
NCT00266032 Contraception Phase 3 Completed - Canada, Quebec ... More >> Drummondville, Quebec, Canada, J2B 1H8 Montreal, Quebec, Canada, H1T 1P6 Pointe-Claire, Quebec, Canada, H9R 4S3 Shawinigan, Quebec, Canada, G9N 2H6 Ste-Foy, Quebec, Canada, G1V 4X7 Canada Quebec, Canada, G1S 2L6 Germany Ettlingen, Baden-Württemberg, Germany, 76275 Karlsruhe, Baden-Württemberg, Germany, 76199 Ansbach, Bayern, Germany, 91522 Krumbach, Bayern, Germany, 86381 Nürnberg, Bayern, Germany, 90491 Dietzenbach, Hessen, Germany, 63128 Frankfurt, Hessen, Germany, 60322 Frankfurt, Hessen, Germany, 60439 Frankfurt, Hessen, Germany, 65929 Frankfurt, Hessen, Germany, 65936 Mühlheim, Hessen, Germany, 63165 Bovenden, Niedersachsen, Germany, 37120 Hannover, Niedersachsen, Germany, 30459 Osnabrück, Niedersachsen, Germany, 49074 Bernburg, Sachsen-Anhalt, Germany, 06406 Jessen, Sachsen-Anhalt, Germany, 06917 Magdeburg, Sachsen-Anhalt, Germany, 39104 Magdeburg, Sachsen-Anhalt, Germany, 39126 Magdeburg, Sachsen-Anhalt, Germany, 39130 Wurzen, Sachsen, Germany, 04808 Gera, Thüringen, Germany, 07545 Jena, Thüringen, Germany, 07747 Kahla, Thüringen, Germany, 07768 Berlin, Germany, 10115 Berlin, Germany, 10247 Berlin, Germany, 12435 Berlin, Germany, 13187 Hamburg, Germany, 21073 Netherlands Groningen, Netherlands, 9713 GZ Less <<
NCT01350336 Severe Asthma Not Applicable Active, not recruiting January 2020 -
NCT01356602 Acute Gouty Arthritis Phase 3 Completed - -
NCT01350804 - Completed - -
NCT01356602 - Completed - -
NCT01358578 Chronic Plaque Psoriasis Phase 3 Completed - -
NCT01359943 - Completed - -
NCT00778895 - Completed - -
NCT01387802 - Active, not recruiting November 30, 2019 -
NCT01377012 Rheumatoid Arthritis Phase 3 Completed - -
NCT01359943 Rheumatoid Arthritis Phase 2 Completed - -
NCT00778895 Influenza Phase 2 Completed - Canada, Alberta ... More >> GSK Investigational Site Calgary, Alberta, Canada, T3B 6A8 Canada, British Columbia GSK Investigational Site Langley, British Columbia, Canada, V3A 4H9 Canada, Manitoba GSK Investigational Site Winnipeg, Manitoba, Canada, R3E 3P4 Canada, Newfoundland and Labrador GSK Investigational Site Mount Pearl, Newfoundland and Labrador, Canada, A1N 5B6 Canada, Nova Scotia GSK Investigational Site Halifax, Nova Scotia, Canada, B3K 6R8 Canada, Ontario GSK Investigational Site Hamilton, Ontario, Canada, L8L 5G8 GSK Investigational Site London, Ontario, Canada, N6A 5R9 GSK Investigational Site London, Ontario, Canada, N6H 4P2 GSK Investigational Site Mississauga, Ontario, Canada, L5A 3V4 GSK Investigational Site Newmarket, Ontario, Canada, L3Y 5G8 GSK Investigational Site Sarnia, Ontario, Canada, N7T 4X3 GSK Investigational Site Sudbury, Ontario, Canada, P3E 1H5 GSK Investigational Site Toronto, Ontario, Canada, M5G 1N8 Canada, Prince Edward Island GSK Investigational Site Charlottetown, Prince Edward Island, Canada, C1A 5N4 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H3T 1C5 GSK Investigational Site Quebec City, Quebec, Canada, G1V 4M6 GSK Investigational Site Ste-Foy, Quebec, Canada, G1X 3V7 GSK Investigational Site Trois Rivières, Quebec, Canada, G8T 7A1 Less <<
NCT00809965 - Completed - -
NCT00809965 Acute Coronary Syndrome ... More >> Myocardial Infarction Myocardial Ischemia Unstable Angina Less << Phase 3 Completed - -
NCT01377012 - Completed - -
NCT00000859 HIV Infections Not Applicable Completed - -
NCT00866918 Childhood Acute Promyelocytic ... More >>Leukemia (M3) Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Less << Phase 3 Completed - -
NCT01470989 Acute Gouty Arthritis Flares Phase 3 Completed - -
NCT01468701 - Active, not recruiting January 14, 2020 -
NCT01431638 Acute Gouty Arthritis Phase 3 Completed - -
NCT01475669 Surgical Blood Loss ... More >> Postoperative Blood Loss Less << Phase 3 Completed - -
NCT00866918 - Completed - -
NCT01209364 Knee Osteoarthritis Phase 3 Completed - Canada, Alberta ... More >> Alberta Bone & Joint Health Institute Calgary, Alberta, Canada, T2P 3C5 Canada, Newfoundland and Labrador Nexus Clinical Research St John´s, Newfoundland and Labrador, Canada, A1B 3E1 Canada, Nova Scotia Orthopaedic & Sport Medicine Institute of Nova Scotia Halifax, Nova Scotia, Canada, B3H 4M2 Dr. Wilson Lunenburg, Nova Scotia, Canada, B0J2C0 Canada, Ontario QEII Health Sciences Centre-New Halifax Infirmary Halifax, Ontario, Canada, B3H 3A7 Charlton Medical Centre Hamilton, Ontario, Canada, L8N 1Y2 MAC Research Inc. Hamilton, Ontario, Canada, L8N 2B6 Fowler Kennedy Sport Medicine Clinic London, Ontario, Canada, N6A 3K7 Credit Valley Rheumatology Mississauga, Ontario, Canada, L5M 2V8 The Arthritis Program Research Group Newmarket, Ontario, Canada, L3Y 3R7 Dr. Dobson Peterborough, Ontario, Canada, K9J 6X2 Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 Sport C.A.R.E. Women's College Hospital Toronto, Ontario, Canada, M5S 1B2 Canada, Quebec Centre de Rhumatologie St-Louis Saint-Foy, Quebec, Canada, G1W4R4 Canada, Saskatchewan Saskatoon Osteoporosis Centre Saskatoon, Saskatchewan, Canada, S7K 0H6 Sweden Läkargruppen Kristinelund Göteborg, Sweden, 411 37 Ortopediska huset Johanneshov, Sweden, 121 77 Läkarhuset Ellenbogen Malmö, Sweden, 211 36 Ortopediska huset Stockholm, Sweden, 11360 United Kingdom Kings College Hospital - Department of Rheumatology London, United Kingdom, SE5 9RS Newcastle University Clinical Research FacilityRoyal Victoria Infirmary Newcastle, United Kingdom, NE1 4LP Robert Jones and Agnes Hunt Orthopaedic & District Hospital - Institute of Orthopaedics Oswestry, United Kingdom, SY10 7AG Southampton General Hospital - MRC Epidemiology Resource Center Southampton, United Kingdom, SO16 6YD Less <<
NCT01487161 Osteoarthritis of the Knee Phase 2 Completed - United States, Arizona ... More >> Tucson, Arizona, United States, 85704 United States, Pennsylvania Duncansville, Pennsylvania, United States, 16635 Australia, New South Wales Broadmeadow, New South Wales, Australia Kogarah, New South Wales, Australia St. Leonards, New South Wales, Australia Wollongong, New South Wales, Australia Australia, Queensland Kippa-Ring, Queensland, Australia Maroochydore, Queensland, Australia Sherwood, Queensland, Australia Australia, Victoria Clayton, Victoria, Australia Malvern East, Victoria, Australia Canada, Nova Scotia Halifax, Nova Scotia, Canada Canada, Ontario Etobicoke, Ontario, Canada Newmarket, Ontario, Canada Sarnia, Ontario, Canada St. Catherine's, Ontario, Canada Thornhill, Ontario, Canada Waterloo, Ontario, Canada Windsor, Ontario, Canada Canada, Quebec Montreal, Quebec, Canada Sainte-Foy, Quebec, Canada Less <<
NCT01487161 - Completed - -
NCT01475825 Hypercholesterolemia ... More >> Heterozygous Familial Less << Phase 3 Completed - -
NCT00909857 Primary Dysmenorrhea Phase 3 Completed - -
NCT01500278 - Completed - -
NCT01500278 Rheumatoid Arthritis Phase 4 Completed - -
NCT00927069 Plaque Psoriasis Phase 3 Completed - Canada, Manitoba ... More >> Winnipeg Clinic Winnipeg, Manitoba, Canada, R3C 0N2 Canada, Newfoundland and Labrador NewLab Clinical Research St-John's, Newfoundland and Labrador, Canada, A1C 2H5 Canada, Ontario Mediprobe Research London, Ontario, Canada, N5X 2P1 The Guenther Dermatology Research center London, Ontario, Canada, N6A 3H7 Lynderm Research Markham, Ontario, Canada, L3P 1A8 Entralogix Inc. Oakville, Ontario, Canada, L6K 1E1 Entralogix Clinical Group Inc. Toronto, Ontario, Canada, M4V 1R1 Windsor Clinical Research Inc. Windsor, Ontario, Canada, N8W 5L7 Canada, Quebec Innovaderm Research Laval Inc. Laval, Quebec, Canada, H7S 2C6 Innovaderm Research Inc Montreal, Quebec, Canada, H2K 4L5 Centre de Recherches Dermatologiques du Quebec Metropolitain Ste-Foy, Quebec, Canada, G1V 4X7 Canada Centre de Recherche Clinique Martin Gilbert inc et Centre Dermatologie Maizerets Quebec, Canada, G1J 1X7 Less <<
NCT00927069 - Completed - -
NCT00929110 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT00930904 - Completed - -
NCT01555710 Extensive-Stage Small Cell Lun... More >>g Cancer Less << Phase 3 Unknown June 2015 -
NCT01559038 - Active, not recruiting November 30, 2019 -
NCT00929110 - Completed - -
NCT01544595 Moderate to Severe Plaque-type... More >> Psoriasis Less << Phase 3 Completed - -
NCT00909857 - Completed - -
NCT01570686 - Completed - -
NCT00949286 - Completed - -
NCT01570686 Hypertension Phase 4 Completed - -
NCT01583374 Ankylosing Spondyloarthritis Phase 3 Active, not recruiting October 2, 2018 -
NCT01576484 Hypercholesterolemia Phase 2 Completed - United States, California ... More >> Mission Viejo, California, United States Newport Beach, California, United States Thousand Oaks, California, United States United States, Florida Miami, Florida, United States Port Orange, Florida, United States United States, Kansas Kansas City, Kansas, United States United States, Maine Auburn, Maine, United States United States, Missouri Saint Louis, Missouri, United States United States, North Carolina Durham, North Carolina, United States United States, Ohio Cincinnati, Ohio, United States United States, Texas Houston, Texas, United States Canada, Quebec Chicoutimi, Quebec, Canada Montreal, Quebec, Canada Sainte-Foy, Quebec, Canada Less <<
NCT01583374 - Active, not recruiting - -
NCT01597635 Lung Injury, Acute Phase 2 Completed - United States, California ... More >> GSK Investigational Site Sacramento, California, United States, 95817 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60611 United States, Massachusetts GSK Investigational Site Springfield, Massachusetts, United States, 01199 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48109 United States, New York GSK Investigational Site New York, New York, United States, 10003 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 GSK Investigational Site Greensboro, North Carolina, United States, 27403 GSK Investigational Site Winston-Salem, North Carolina, United States, 27517 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43215 United States, Oregon GSK Investigational Site Portland, Oregon, United States, 97239 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 GSK Investigational Site Philadelphia, Pennsylvania, United States, 19107 United States, South Carolina GSK Investigational Site Charleston, South Carolina, United States, 29425 Canada, British Columbia GSK Investigational Site Vancouver, British Columbia, Canada, V5Z 1M9 GSK Investigational Site Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Nova Scotia GSK Investigational Site Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Ontario GSK Investigational Site Kingston, Ontario, Canada, K7L 2V7 Canada, Quebec GSK Investigational Site Greenfield Park, Quebec, Canada, J4V 2H1 GSK Investigational Site Sainte-Foy, Quebec, Canada, G1V 4G5 Less <<
NCT01597245 Psoriasis Phase 3 Active, not recruiting July 2019 -
NCT01597245 - Active, not recruiting - -
NCT01026220 Childhood Nodular Lymphocyte P... More >>redominant Hodgkin Lymphoma Stage III Childhood Hodgkin Lymphoma Stage IV Childhood Hodgkin Lymphoma Less << Phase 3 Completed - -
NCT01026090 Atrial Fibrillation Phase 4 Terminated('Sponsor decision f... More >>ollowing recruitment issues, not related to any safety concerns in the study) Less << - Canada ... More >> Investigational Site Number 1240033 Abbotsford, Canada, V2S3N5 Investigational Site Number 1240026 Barrie, Canada, L4M4S5 Investigational Site Number 1240050 Calgary, Canada, T2E7C5 Investigational Site Number 1240010 Cambridge, Canada, N1R6V6 Investigational Site Number 1240049 Edmonton, Canada, T5H4B9 Investigational Site Number 1240005 Granby, Canada, J2G1T7 Investigational Site Number 1240001 Greenfield Park, Canada, J4V2G8 Investigational Site Number 1240046 Grimsby, Canada, L3M 1P3 Investigational Site Number 1240040 Hamilton, Canada, L8L 2X2 Investigational Site Number 1240037 Hamilton, Canada, L8N 3Z5 Investigational Site Number 1240044 Kingston, Canada, K7L2V7 Investigational Site Number 1240029 Kitchener, Canada, N2N2A8 Investigational Site Number 1240013 Laval, Canada, H7S2M5 Investigational Site Number 1240043 Levis, Canada, G6V3Z1 Investigational Site Number 1240038 Maple Ridge, Canada, V2X5Z6 Investigational Site Number 1240023 Montreal, Canada, H1T1C8 Investigational Site Number 1240006 Montreal, Canada, H3G 1A4 Investigational Site Number 1240008 Montreal, Canada, H4J1C5 Investigational Site Number 1240018 Newmarket, Canada, L3Y8C3 Investigational Site Number 1240012 Niagara Falls, Canada, L2E7H1 Investigational Site Number 1240020 North York, Canada, M2J1W8 Investigational Site Number 1240015 Oshawa, Canada, L1J2J9 Investigational Site Number 1240036 Oshawa, Canada Investigational Site Number 1240024 Ottawa, Canada, K1Y4W7 Investigational Site Number 1240032 Ottawa, Canada, K2G3M8 Investigational Site Number 1240056 Red Deer, Canada, T4N4E7 Investigational Site Number 1240053 Saskatoon, Canada, S7N0W8 Investigational Site Number 1240016 Scarborough, Canada, M1E5E9 Investigational Site Number 1240027 Sherbrooke, Canada, J1H 5N4 Investigational Site Number 1240003 St-Charles Borromee, Canada, J6E6J2 Investigational Site Number 1240007 St-Georges, Canada, G5Y 4T8 Investigational Site Number 1240041 St. John, Canada, E2L 4L2 Investigational Site Number 1240002 Ste-Foy, Canada, G1V4G5 Investigational Site Number 1240021 Sudbury, Canada, P3C5K7 Investigational Site Number 1240039 Sudbury, Canada, P3E2N8 Investigational Site Number 1240025 Toronto, Canada, M4N3M5 Investigational Site Number 1240011 Toronto, Canada, M5C 2T2 Investigational Site Number 1240019 Toronto, Canada, M5G2C4 Investigational Site Number 1240009 Trois-Rivières, Canada, G8Z 4K4 Investigational Site Number 1240047 Vancouver, Canada, V5Z1M6 Investigational Site Number 1240035 Victoria, Canada, V8R4R2 Investigational Site Number 1240014 Willowdale, Canada, M2K2W2 Investigational Site Number 1240051 Windsor, Canada, N8X3N9 Less <<
NCT01026220 - Completed - -
NCT01643408 Acute Lymphoblastic Leukemia ... More >> Lymphoblastic Lymphoma Less << Phase 2 Completed - -
NCT01636687 Plaque-type Psoriasis Phase 3 Completed - -
NCT01609140 Coronary Heart Disease Phase 2 Completed - -
NCT00993382 Arrhythmia Prophylaxis ... More >> Ventricular Arrhythmia Less << Phase 2 Completed - -
NCT01649375 Anklyosing Spondylitis Phase 3 Completed - -
NCT01597635 - Completed - -
NCT01040130 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - Australia, South Australia ... More >> 1222.37.6171 Boehringer Ingelheim Investigational Site Daw Park, South Australia, Australia Australia, Victoria 1222.37.6174 Boehringer Ingelheim Investigational Site Clayton, Victoria, Australia 1222.37.6173 Boehringer Ingelheim Investigational Site Heidelberg, Victoria, Australia 1222.37.6172 Boehringer Ingelheim Investigational Site Melbourne, Victoria, Australia Austria 1222.37.4371 Boehringer Ingelheim Investigational Site Gänserndorf, Austria 1222.37.4372 Boehringer Ingelheim Investigational Site Neumarkt am Wallersee, Austria Canada, Ontario 1222.37.1072 Boehringer Ingelheim Investigational Site Hamilton, Ontario, Canada Canada, Quebec 1222.37.1074 Boehringer Ingelheim Investigational Site Montreal, Quebec, Canada 1222.37.1073 Boehringer Ingelheim Investigational Site Ste-Foy, Quebec, Canada France 1222.37.33005 Boehringer Ingelheim Investigational Site Bethune Cedex, France 1222.37.33002 Boehringer Ingelheim Investigational Site Montpellier, France 1222.37.33001 Boehringer Ingelheim Investigational Site Nîmes, France 1222.37.33006 Boehringer Ingelheim Investigational Site Paris, France 1222.37.33004 Boehringer Ingelheim Investigational Site Perpignan, France 1222.37.33003 Boehringer Ingelheim Investigational Site Strasbourg, France Germany 1222.37.4970 Boehringer Ingelheim Investigational Site Berlin, Germany 1222.37.4972 Boehringer Ingelheim Investigational Site Halle, Germany 1222.37.4973 Boehringer Ingelheim Investigational Site Magdeburg, Germany 1222.37.4971 Boehringer Ingelheim Investigational Site Rüdersdorf, Germany Less <<
NCT01663402 Acute Coronary Syndrome Phase 3 Completed - -
NCT01040130 - Completed - -
NCT01636687 - Completed - -
NCT01665053 - Active, not recruiting - -
NCT00831441 Acute Coronary Syndrome Phase 3 Terminated - -
NCT00831441 - Terminated - -
NCT01687998 Cardiovascular Diseases Phase 3 Terminated(Study termination d... More >>ue to insufficient efficacy.) Less << - -
NCT01072396 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 4 Completed - United States, Alabama ... More >> 205.440.1006 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States 205.440.1015 Boehringer Ingelheim Investigational Site Jasper, Alabama, United States United States, California 205.440.1002 Boehringer Ingelheim Investigational Site Torrance, California, United States United States, Connecticut 205.440.1018 Boehringer Ingelheim Investigational Site Hartford, Connecticut, United States United States, Illinois 205.440.1008 Boehringer Ingelheim Investigational Site Springfield, Illinois, United States United States, Indiana 205.440.1017 Boehringer Ingelheim Investigational Site Muncie, Indiana, United States United States, Michigan 205.440.1020 Boehringer Ingelheim Investigational Site Livonia, Michigan, United States United States, New Hampshire 205.440.1011 Boehringer Ingelheim Investigational Site Lebanon, New Hampshire, United States United States, North Carolina 205.440.1019 Boehringer Ingelheim Investigational Site Charlotte, North Carolina, United States United States, Pennsylvania 205.440.1013 Boehringer Ingelheim Investigational Site Pittsburgh, Pennsylvania, United States United States, South Carolina 205.440.1007 Boehringer Ingelheim Investigational Site Spartanburg, South Carolina, United States Canada, Ontario 205.440.2003 Boehringer Ingelheim Investigational Site Kingston, Ontario, Canada Canada, Quebec 205.440.2001 Boehringer Ingelheim Investigational Site Montreal, Quebec, Canada 205.440.2004 Boehringer Ingelheim Investigational Site Montreal, Quebec, Canada 205.440.2002 Boehringer Ingelheim Investigational Site Ste-Foy, Quebec, Canada Less <<
NCT01072396 - Completed - -
NCT01675882 Peanut Allergy Phase 2 Completed - United States, California ... More >> University of California, Rady Childrens Hospital San Diego, California, United States, 92123 Stanford University School of Medicine Stanford, California, United States, 94305 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Boston Childrens' Hospital Boston, Massachusetts, United States, 02115 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Children's Medical Center Dallas Dallas, Texas, United States, 75235 United States, Washington ASTHMA, Inc. Seattle, Washington, United States, 98115 Canada, Ontario Cheema Research Inc. Mississauga, Ontario, Canada, L5A 3V4 Ottawa Allergy Asthma Research Institute Ottawa, Ontario, Canada, K1Y 4G2 Gordon Sussman Clinical Research Toronto, Ontario, Canada, M4V 1R2 Canada, Quebec Centre de Recherche Appliquée en Asthme et Allergie de Québec Sainte-Foy, Quebec, Canada, G1V 4M6 France Centre Hospitalier Universitaire de Bordeaux, Hôpital Pellegrin Bordeaux, France, 33076 Hôpital Saint Vincent de Paul Lille, France, 59020 GCS des hôpitaux pédiatriques Nice, France, 06200 Hôpital Necker Paris, France, 75743 Nouvel Hôpital Civil Strasbourg, France, 67091 Hôpitaux De Brabois Vandoeuvre-les-Nancy, France, 54511 Netherlands Erasmus MC Rotterdam, Netherlands, 3015 GD UMC Utrecht Utrecht, Netherlands, 3584 CX Poland Szpital Uniwersytecki nr2 Bydgoszcz, Poland, 85168 Szpital Kliniczny UM Łódź, Poland, 92213 Less <<
NCT01689519 Malignant Melanoma Phase 3 Active, not recruiting December 28, 2019 -
NCT01076348 - Completed - -
NCT01665053 Coronary Artery Disease Phase 3 Active, not recruiting January 2019 -
NCT01076348 - Completed - -
NCT01076361 - Completed - -
NCT01694394 - Completed - Canada, Alberta ... More >> University of Calgary Calgary, Alberta, Canada, T2N 2T9 Canada, Manitoba St. Boniface Hospital Winnepeg, Manitoba, Canada, R2H 2A6 Canada, Nova Scotia Queen Elizabeth-II Heather Sciences Center Halifax, Nova Scotia, Canada, B3H 3A7 Canada, Ontario Hamilton Health Sciences - Electrophysiology Clinic Hamilton, Ontario, Canada, L8L 2X2 Hamilton Health Sciences - Interventional Cardiology Hamilton, Ontario, Canada, L8L 2X2 Hamilton Health Sciences - Perioperative Ischemia Research Group Hamilton, Ontario, Canada, L8L 2X2 London Health Sciences Center University Hospital London, Ontario, Canada, N6A 5A5 Southlake Regional HealthCare Newmarket, Ontario, Canada, L3Y 2P9 University of Ottawa Heart Institute Ottawa, Ontario, Canada, 613-761-5208 Health Sciences North Sudbury, Ontario, Canada, P3E 5J1 University Health Network Toronto, Ontario, Canada, M5G 2C4 Canada, Quebec McGill University Health Centre Montreal, Quebec, Canada, H9S 1H4 Institut Universitaire de Cardiologie et de Pneumologie de Quebec (Hopital Laval) Sainte-Foy, Quebec, Canada, G1V 4G5 Netherlands Academisch Medisch Centrum (AMC) Amsterdam Amsterdam, Netherlands, 1100 DD Amphia Hospital Breda, Netherlands, 4818 CK Nij Smellinge Drachten, Netherlands, 9202 DA Groene Hart Ziekenhuis Gouda Gouda, Netherlands, 2803 HH Diakonessenhuis Leiden Leiden, Netherlands, 2334 CK Ikazia Hospital Rotterdam, Netherlands, 3083 AN Less <<
NCT01709513 Hypercholesterolemia Phase 3 Completed - -
NCT01687998 - Terminated(Study termination d... More >>ue to insufficient efficacy.) Less << - -
NCT01709110 - Completed - -
NCT01752634 Psoriatic Arthritis Phase 3 Active, not recruiting January 18, 2019 -
NCT01709513 - Completed - -
NCT01757067 Premature Ventricular Contract... More >>ions Congestive Heart Failure Less << Not Applicable Terminated(Unable to recruit s... More >>ufficient participants) Less << - United States, California ... More >> UCLA Los Angeles, California, United States, 90095 United States, Maryland University of Maryland Medical Center Baltimore, Maryland, United States, 21201 United States, Massachusetts Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109-311 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210-1252 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Canada, Quebec University of Quebec Sainte-Foy, Quebec, Canada, G1V4G5 Less <<
NCT01709110 Postmenopausal Osteoporosis Phase 4 Completed - -
NCT01763164 Metastatic or Unresectable Cut... More >>aneous Melanoma Less << Phase 3 Active, not recruiting July 31, 2019 -
NCT01076361 - Completed - -
NCT01823016 Asthma Phase 2 Completed - -
NCT01843374 Unresectable Pleural or Perito... More >>neal Malignant Mesothelioma Less << Phase 2 Active, not recruiting April 2, 2019 -
NCT01689519 - Active, not recruiting - -
NCT01154140 - Completed - -
NCT01219621 Any Patient Who Fulfills the I... More >>nclusion Criteria to be Implanted With a Dual Chamber Pacemaker Maybe Included in the Study as Per ACC/AHA Guidelines Less << Phase 3 Completed - Canada, Alberta ... More >> Grey Nuns hospital Edmonton, Alberta, Canada, T6L 5X8 Royal-Alex hospital Edmonton, Alberta, Canada Canada, Ontario Kingston General Hospital Kingston, Ontario, Canada, K7L 2V7 Southlake hospital Newmarket, Ontario, Canada St Mike's hospital Toronto, Ontario, Canada Canada, Quebec Institute de Cardilogie, Montreal Heart Institute Montreal, Quebec, Canada, H1t 1c8 Hotel-Dieu St Jerome St Jerome, Quebec, Canada, J7Z 5T3 Laval hospital Ste Foy, Quebec, Canada Trois-Riviere general hospital Trois-Rivieres, Quebec, Canada Canada, Saskatchewan SASKATOON hospital Saskatoon, Saskatchewan, Canada Less <<
NCT00607373 Lipid Metabolism, Inborn Error... More >>s Hypercholesterolemia, Autosomal Dominant Hyperlipidemias Metabolic Diseases Hyperlipoproteinemia Type II Metabolism, Inborn Errors Genetic Diseases, Inborn Infant, Newborn, Diseases Metabolic Disorder Congenital Abnormalities Hypercholesterolemia Hyperlipoproteinemias Dyslipidemias Lipid Metabolism Disorders Less << Phase 3 Completed - United States, North Carolina ... More >> Charlotte, North Carolina, United States, 28204 United States, Ohio Cincinnati, Ohio, United States, 45212 Brazil Sao Paulo, SP, Brazil, 05403-000 Canada, Quebec Chicoutimi, Quebec, Canada, G7H 5H6 Ste Foy, Quebec, Canada, G1V 4G2 Singapore Mistri Wing, Singapore, 168752 South Africa Observatory, South Africa, 7925 Parktown, South Africa, 2193 Taiwan Taipei, Taiwan, 11217 United Kingdom London, United Kingdom, WC1N 3BG Less <<
NCT01867762 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 2 Completed - -
NCT01154140 Non Squamous Lung Cancer Phase 3 Completed - -
NCT01870284 Spondylitis, Ankylosing Phase 3 Withdrawn(Due to unexpected op... More >>erational issues outside of Lilly's control the study has been closed) Less << April 2018 -
NCT01843374 - Active, not recruiting - -
NCT01870778 Acute Heart Failure Phase 3 Completed - -
NCT01912560 Dyslipidemia ... More >>Hypercholesterolemia Hypertriglyceridemia Less << Phase 2 Completed - United States, Alabama ... More >> Muscle Shoals, Alabama, United States, 35662 United States, California Los Angeles, California, United States, 90057 United States, Florida Jacksonville, Florida, United States, 32223 Miami, Florida, United States, 33143 Winter Park, Florida, United States, 32792 United States, Kansas Kansas City, Kansas, United States, 66160 United States, Kentucky Louisville, Kentucky, United States, 40213 United States, Maine Auburn, Maine, United States, 04120 United States, North Carolina Raleigh, North Carolina, United States, 27609 Raleigh, North Carolina, United States, 27612 United States, Ohio Cincinnati, Ohio, United States, 45219 Cincinnati, Ohio, United States, 45227 Cincinnati, Ohio, United States, 45246 Canada, Quebec Sainte-Foy, Quebec, Canada, G1V 4M6 Less <<
NCT01870778 - Completed - -
NCT01934192 Gastroparesis Phase 2 Terminated - United States, Colorado ... More >> GSK Investigational Site Aurora, Colorado, United States, 80045 United States, Georgia GSK Investigational Site Augusta, Georgia, United States, 30909 United States, Kentucky GSK Investigational Site Louisville, Kentucky, United States, 40202 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 Australia, New South Wales GSK Investigational Site Randwick, New South Wales, Australia, 2031 Australia, Queensland GSK Investigational Site Southport, Queensland, Australia, 4215 Australia, South Australia GSK Investigational Site Adelaide, South Australia, Australia, 5000 GSK Investigational Site Woodville, South Australia, Australia, 5011 Canada, Alberta GSK Investigational Site Calgary, Alberta, Canada, T1Y 6J4 GSK Investigational Site Calgary, Alberta, Canada, T2N 2T9 Canada, Ontario GSK Investigational Site Hamilton, Ontario, Canada, L8L 2X2 GSK Investigational Site Kingston, Ontario, Canada, K7L 2V7 GSK Investigational Site Ottawa, Ontario, Canada, K1H 8L6 GSK Investigational Site Ottawa, Ontario, Canada, K1Y 4E9 GSK Investigational Site Toronto, Ontario, Canada, M5G 1X5 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2X 3J4 GSK Investigational Site Sainte-Foy, Quebec, Canada, G1V 4G5 GSK Investigational Site Sherbrooke, Quebec, Canada, J1H 5N4 Canada GSK Investigational Site Quebec, Canada, G1J 1Z4 Less <<
NCT01920711 Heart Failure With Preserved E... More >>jection Fraction Less << Phase 3 Active, not recruiting May 31, 2019 -
NCT00607373 - Completed - -
NCT01281306 Systolic Hypertension Phase 2 Completed - -
NCT02200419 Heart Diseases Not Applicable Completed - Canada, Alberta ... More >> Dr. Charles McAdams Calgary, Alberta, Canada, T2N 2T9 Blaine Achen Edmonton, Alberta, Canada Canada, British Columbia Dr. Terry Waters Vancouver, British Columbia, Canada, V5Z 1M9 Dr. Sukhpal Brar Vancouver, British Columbia, Canada Canada, Manitoba Dr. H. Grocott Winnipeg, Manitoba, Canada, R2H 2A6 Canada, Ontario Dr. Summer Syed Hamilton, Ontario, Canada, L8N 3Z5 Dr. Christopher Harle London, Ontario, Canada, N6A 5A5 Dr. Daniel Kim Newmarket, Ontario, Canada, L3Y 2P9 Dr. D. Tran Ottawa, Ontario, Canada, K1Y 4W7 Dr. F. Moussa Toronto, Ontario, Canada, M4N 3M5 Canada, Quebec Dr. E. Medicis Fleurimont, Quebec, Canada, J1H 5N4 Dr. J. Bussieres Sainte -Foy, Quebec, Canada, G1V 4G5 Less <<
NCT02006069 Heart Failure Not Applicable Recruiting May 2020 -
NCT01281306 - Completed - -
NCT02008344 Influenza Phase 3 Completed - -
NCT01934192 - Terminated - -
NCT02054481 Psoriasis Phase 2 Completed - -
NCT01955109 Peanut Allergy Phase 2 Completed - United States, California ... More >> University of California, Rady Childrens Hospital San Diego, California, United States, 92123 Stanford University School of Medicine Stanford, California, United States, 94305 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60611 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Boston Childrens' Hospital Boston, Massachusetts, United States, 02115 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Children's Medical Center Dallas Dallas, Texas, United States, 75235 United States, Washington ASTHMA, Inc. Seattle, Washington, United States, 98115 Canada, Ontario Cheema Research Inc. Mississauga, Ontario, Canada, L5A 3V4 Ottawa Allergy Asthma Research Institute Ottawa, Ontario, Canada, K1Y 4G2 Gordon Sussman Clinical Research Toronto, Ontario, Canada, M4V 1R2 Canada, Quebec Centre de Recherche Appliquée en Asthme et Allergie de Québec Sainte-Foy, Quebec, Canada, G1V 4M6 France Centre Hospitalier Universitaire de Bordeaux, Hôpital Pellegrin Bordeaux, France, 33076 Hôpital Saint Vincent de Paul Lille, France, 59020 GCS des hôpitaux pédiatriques Nice, France, 06200 Hôpital Necker Paris, France, 75743 Nouvel Hôpital Civil Strasbourg, France, 67091 Hôpitaux De Brabois Vandoeuvre-les-Nancy, France, 54511 Netherlands Erasmus MC Rotterdam, Netherlands, 3015 GD UMC Utrecht Utrecht, Netherlands, 3584 CX Less <<
NCT02074982 Chronic Plaque Type Psoriasis Phase 3 Completed - -
NCT02074982 - Completed - -
NCT02105948 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - -
NCT02106546 Squamous Non-Small Cell Lung C... More >>ancer Less << Phase 3 Active, not recruiting July 15, 2019 -
NCT02054481 - Completed - -
NCT02105948 - Completed - -
NCT02135692 Asthma Phase 3 Completed - -
NCT02135692 - Completed - -
NCT01431287 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - -
NCT02211209 Familial Chylomicronemia Syndr... More >>ome Less << Phase 3 Completed - -
NCT02139943 Diabetes Mellitus, Type 1 Phase 2 Completed - -
NCT02139943 - Completed - -
NCT01502410 - Completed - -
NCT02198651 Rheumatoid Arthritis ... More >> Musculoskeletal and Connective Tissue Diseases Less << Phase 4 Completed - -
NCT01502410 Childhood Hepatocellular Carci... More >>noma Papillary Thyroid Cancer Previously Treated Childhood Rhabdomyosarcoma Recurrent Childhood Liver Cancer Recurrent Childhood Rhabdomyosarcoma Recurrent Thyroid Cancer Recurrent Wilms Tumor and Other Childhood Kidney Tumors Less << Phase 2 Completed - -
NCT00850642 Asthma Phase 2 Terminated - Canada, Ontario ... More >> GSK Investigational Site Hamilton, Ontario, Canada, L8N 4A6 GSK Investigational Site Kingston, Ontario, Canada, K7L 2V6 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H4J 1C5 GSK Investigational Site Sainte-Foy, Quebec, Canada, G1V 4G5 United Kingdom GSK Investigational Site Glasgow, Lanarkshire, United Kingdom, G12 0YN GSK Investigational Site Leicester, Leicestershire, United Kingdom, LE3 9QP GSK Investigational Site London, United Kingdom, NW10 7EW GSK Investigational Site Manchester, United Kingdom, M23 9QZ Less <<
NCT01431287 - Completed - -
NCT00850642 - Terminated - -
NCT00206583 Contraception Phase 3 Completed - -
NCT00219544 Neuropathic Pain Phase 3 Completed - Canada, Alberta ... More >> Pfizer Investigational Site Calgary, Alberta, Canada, T2N 4N1 Pfizer Investigational Site Calgary, Alberta, Canada, T2S 3C3 Pfizer Investigational Site Calgary, Alberta, Canada, T3B 0M3 Pfizer Investigational Site Edmonton, Alberta, Canada, T5J 3N4 Pfizer Investigational Site Edmonton, Alberta, Canada, T5N 3Y6 Pfizer Investigational Site Red Deer, Alberta, Canada, T4N 6V7 Canada, British Columbia Pfizer Investigational Site Kelowna, British Columbia, Canada, V1Y 2H4 Pfizer Investigational Site Vancouver, British Columbia, Canada, V6E 1M7 Pfizer Investigational Site Vancouver, British Columbia, Canada, V6Z 2E8 Canada, Manitoba Pfizer Investigational Site Winnipeg, Manitoba, Canada, R2V 4W3 Pfizer Investigational Site Winnipeg, Manitoba, Canada, R3A 1R9 Pfizer Investigational Site Winnipeg, Manitoba, Canada, R3E 3P4 Canada, Nova Scotia Pfizer Investigational Site Halifax, Nova Scotia, Canada, B3J 3T1 Canada, Ontario Pfizer Investigational Site Kingston, Ontario, Canada, K7L 2V7 Pfizer Investigational Site London, Ontario, Canada, N6A 4V2 Pfizer Investigational Site Port Hope, Ontario, Canada, L1A 3Y9 Pfizer Investigational Site Toronto, Ontario, Canada, M5G 2N2 Canada, Prince Edward Island Pfizer Investigational Site Charlottetown, Prince Edward Island, Canada, C1E 1J7 Canada, Quebec Pfizer Investigational Site Granby, Quebec, Canada, J2G 8Z9 Pfizer Investigational Site Laval, Quebec, Canada, H7M 3L9 Pfizer Investigational Site Laval, Quebec, Canada, H7T 2P5 Pfizer Investigational Site Levis, Quebec, Canada, G6V 3Z1 Pfizer Investigational Site Mirabel, Quebec, Canada, J7J 2K8 Pfizer Investigational Site Montreal, Quebec, Canada, H3A 2B4 Pfizer Investigational Site Montreal, Quebec, Canada, H3G 1A4 Pfizer Investigational Site Montreal, Quebec, Canada, H3T 1E2 Pfizer Investigational Site Sherbrooke, Quebec, Canada, J1H 5N4 Pfizer Investigational Site Sherbrook, Quebec, Canada, J1H 4J6 Pfizer Investigational Site Ste-Foy, Quebec, Canada, G1V 4X7 Canada, Saskatchewan Pfizer Investigational Site Saskatoon, Saskatchewan, Canada, S7N 0W8 Less <<
NCT00673556 Chronic Plaque Psoriasis Phase 3 Completed - -
NCT00219544 - Completed - -
NCT00676052 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - -
NCT00095342 Rheumatoid Arthritis Phase 2 Completed - United States, Indiana ... More >> Indianapolis, Indiana, United States, 46250 United States, New York Syracuse, New York, United States, 13210 United States, Pennsylvania Duncansville, Pennsylvania, United States, 16635 West Reading, Pennsylvania, United States, 19611 Canada, Quebec Montreal, Quebec, Canada, H2L 1S6 Ste-Foy, Quebec, Canada, G1W 4R4 Trois-Rivieres, Quebec, Canada, G8Z 1Y2 Canada, Saskatchewan Saskatoon, Saskatchewan, Canada, S7K 0H6 Less <<
NCT00240318 Coronary Arteriosclerosis Phase 3 Completed - -
NCT00242775 Asthma Phase 3 Completed - -
NCT00240435 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - -
NCT00676052 - Completed - -
NCT00242801 NSCLC Phase 3 Completed - -
NCT00692172 Psoriasis Phase 3 Completed - -
NCT00242346 Proteinuria Phase 3 Completed - Canada, Alberta ... More >> Research Site Calgary, Alberta, Canada Research Site Edmonton, Alberta, Canada Canada, British Columbia Research Site Kelowna, British Columbia, Canada Research Site Vancouver, British Columbia, Canada Canada, Manitoba Research Site Winnipeg, Manitoba, Canada Canada, Newfoundland and Labrador Research Site St. John, Newfoundland and Labrador, Canada Canada, Nova Scotia Research Site Halifax, Nova Scotia, Canada Canada, Ontario Research Site Courtice, Ontario, Canada Research Site Kitchener, Ontario, Canada Research Site London, Ontario, Canada Research Site Mississauga, Ontario, Canada Research Site Oakville, Ontario, Canada Research Site Oshawa, Ontario, Canada Research Site Richmond Hill, Ontario, Canada Research Site Scarborough, Ontario, Canada Research Site Sudbury, Ontario, Canada Research Site Thunder Bay, Ontario, Canada Research Site Timmins, Ontario, Canada Research Site Toronto, Ontario, Canada Research Site Weston, Ontario, Canada Canada, Quebec Research Site Greenfield Park, Quebec, Canada Research Site Laval, Quebec, Canada Research Site Montreal, Quebec, Canada Research Site Quebec City, Quebec, Canada Research Site Ste-Foy, Quebec, Canada Canada, Saskatchewan Research Site Saskatoon, Saskatchewan, Canada Less <<
NCT00245739 - - - -
NCT00334152 Nausea and Vomiting, Postopera... More >>tive Postoperative Nausea and Vomiting Less << Phase 3 Completed - -
NCT00696020 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 2 Completed - -
NCT00246987 Diabetes, Type 2 Phase 3 Completed - -
NCT00696020 - Completed - -
NCT00699998 Acute Coronary Syndrome Phase 3 Completed - -
NCT00699998 - Completed - -
NCT00249899 Hypercholesterolemia Phase 3 Terminated(Overall profile of ... More >>the compound does not offer significant clinical advantage to patients over currently available lipid lowering agents) Less << - -
NCT00705913 Aortic Valve Disease Not Applicable Terminated - United States, California ... More >> Sharp Memorial Hospital San Diego, California, United States, 92123 United States, Florida Pepin Heart Hospital Tampa, Florida, United States, 33613 United States, Kansas St. Luke's Medical Center Kansas City, Kansas, United States, 64111 United States, Maryland Peninsula Regional Medical Center Salisbury, Maryland, United States, 21801 United States, Missouri St. John's Medical Research Inst. Springfield, Missouri, United States, 65807 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 United States, North Carolina Duke University Hospital Durham, North Carolina, United States, 27705 United States, Ohio The Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Pennsylvania Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas The Heart Hospital Baylor Plano Plano, Texas, United States, 75093 Canada, Manitoba St.Boniface General Hospital Winnipeg, Manitoba, Canada, R2H 2A6 Canada, Quebec Hopital Laval Sainte-Foy, Quebec, Canada, G1V 6G5 Less <<
NCT00717236 Rheumatoid Arthritis Phase 3 Completed - -
NCT00249912 Hypercholesterolemia Phase 3 Completed - -
NCT00262522 Human Immunodeficiency Virus I... More >>nfections Less << Phase 3 Completed - -
NCT00717236 - Completed - -
NCT00251537 HIV Infections Phase 2 Completed - Canada, British Columbia ... More >> Centre for HIV/AIDS, St Pauls Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Ontario McMaster University Hamilton, Ontario, Canada, L8N3Z5 The Ottawa Hospital (General Campus) Ottawa, Ontario, Canada, K1H 8L6 University Health Network Toronto, Ontario, Canada, M5G2M9 Canada, Quebec Centre hospitalier de l'Université de Montréal Montreal, Quebec, Canada, H2W 1T8 Research Institute of the McGill University Health Centre Montreal, Quebec, Canada, H3G 1A4 Centre Hospitalier Universitaire de Quebec Ste-Foy, Quebec, Canada, G1V 4G2 Less <<
NCT00262600 - Completed - -
NCT00263276 Type 2 Diabetes Phase 2 Completed - -
NCT00718861 Post-menopausal Osteoporosis Phase 3 Completed - -
NCT00262600 Atrial Fibrillation ... More >> Stroke Less << Phase 3 Completed - -
NCT00720798 Rheumatoid Arthritis Phase 3 Completed - -
NCT00262522 - Completed - -
NCT00721123 Rheumatoid Arthritis Phase 3 Completed - -
NCT00270933 - Completed - -
NCT00721123 - Completed - -
NCT00274508 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - -
NCT00718861 - Completed - -
NCT00720798 - Completed - -
NCT00277264 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - -
NCT00274937 - Completed - -
NCT00279760 Rheumatoid Arthritis Phase 1 Phase 2 Completed - -
NCT00281099 Heart Disease Not Applicable Terminated(Inability to reach ... More >>statistical significance toward primary endpoint) Less << - -
NCT00293059 Metrorrhagia Phase 3 Completed - -
NCT00274937 Stage I Lymphoepithelioma of t... More >>he Nasopharynx Stage I Squamous Cell Carcinoma of the Nasopharynx Stage II Lymphoepithelioma of the Nasopharynx Stage II Squamous Cell Carcinoma of the Nasopharynx Stage III Lymphoepithelioma of the Nasopharynx Stage III Squamous Cell Carcinoma of the Nasopharynx Stage IV Lymphoepithelioma of the Nasopharynx Stage IV Squamous Cell Carcinoma of the Nasopharynx Less << Phase 3 Completed - -
NCT00293059 - Completed - -
NCT00295633 - Completed - -
NCT00281099 - Terminated(Inability to reach ... More >>statistical significance toward primary endpoint) Less << - -
NCT00286481 Hypercholesterolemia Phase 3 Completed - -
NCT00768300 Idiopathic Pulmonary Fibrosis Phase 3 Terminated(Lack of efficacy) - -
NCT00295633 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00773734 Psoriasis Pla... More >>que-type Psoriasis Less << Phase 2 Completed - -
NCT00304070 Stage I Adrenocortical Carcino... More >>ma Stage II Adrenocortical Carcinoma Stage III Adrenocortical Carcinoma Stage IV Adrenocortical Carcinoma Less << Phase 3 Completed - -
NCT00768300 - Terminated(Lack of efficacy) - -
NCT00773734 - Completed - -
NCT00304070 - Completed - -
NCT00312806 Gastroesophageal Reflux Diseas... More >>e (GERD) Less << Phase 3 Completed - -
NCT00326053 Asthma Phase 3 Completed - Canada, Alberta ... More >> Research Site Calgary, Alberta, Canada Research Site Edmonton, Alberta, Canada Research Site Lethbridge, Alberta, Canada Research Site St. Albert, Alberta, Canada Canada, British Columbia Research Site Nanaimo, British Columbia, Canada Research Site Vancouver, British Columbia, Canada Canada, Nova Scotia Research Site Halifax, Nova Scotia, Canada Research Site Truro, Nova Scotia, Canada Canada, Ontario Research Site Hamilton, Ontario, Canada Research Site Kingston, Ontario, Canada Research Site Niagara Falls, Ontario, Canada Research Site Ottawa, Ontario, Canada Research Site Thunder Bay, Ontario, Canada Research Site Toronto, Ontario, Canada Canada, Prince Edward Island Research Site Charlottetown, Prince Edward Island, Canada Canada, Quebec Research Site La Malbaie, Quebec, Canada Research Site Montreal, Quebec, Canada Research Site Ste-Foy, Quebec, Canada Canada, Saskatchewan Research Site Saskatoon, Saskatchewan, Canada Canada Research Site Quebec, Canada Less <<
NCT00806923 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 3 Completed - -
NCT00330785 Hypertension ... More >>Dyslipidemia Less << Phase 3 Completed - -
NCT00785954 Myocardial Infarction ... More >> Cardiovascular Diseases Pathologic Processes Less << Phase 2 Completed - -
NCT00804141 Constipation Phase 3 Completed - -
NCT00336024 - Completed - -
NCT00336024 Untreated Childhood Medullobla... More >>stoma Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor Less << Phase 3 Completed - -
NCT00335556 Childhood Renal Cell Carcinoma... More >> Clear Cell Renal Cell Carcinoma Clear Cell Sarcoma of the Kidney Papillary Renal Cell Carcinoma Rhabdoid Tumor of the Kidney Stage I Renal Cell Cancer Stage I Renal Wilms Tumor Stage II Renal Cell Cancer Stage II Renal Wilms Tumor Stage III Renal Cell Cancer Stage III Renal Wilms Tumor Stage IV Renal Cell Cancer Stage IV Renal Wilms Tumor Less << Phase 2 Completed - -
NCT00660179 Pulmonary Arterial Hypertensio... More >>n Less << Phase 3 Completed - -
NCT00346164 - Completed - -
NCT00845728 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT00335556 - Completed - -
NCT00660179 - Completed - -
NCT00346164 Adult Alveolar Soft-part Sarco... More >>ma Adult Angiosarcoma Adult Epithelioid Sarcoma Adult Extraskeletal Chondrosarcoma Adult Extraskeletal Osteosarcoma Adult Fibrosarcoma Adult Leiomyosarcoma Adult Liposarcoma Adult Malignant Fibrous Histiocytoma Adult Malignant Hemangiopericytoma Adult Malignant Mesenchymoma Adult Neurofibrosarcoma Adult Synovial Sarcoma Childhood Alveolar Soft-part Sarcoma Childhood Angiosarcoma Childhood Epithelioid Sarcoma Childhood Fibrosarcoma Childhood Leiomyosarcoma Childhood Liposarcoma Childhood Malignant Mesenchymoma Childhood Neurofibrosarcoma Childhood Synovial Sarcoma Dermatofibrosarcoma Protuberans Metastatic Childhood Soft Tissue Sarcoma Nonmetastatic Childhood Soft Tissue Sarcoma Stage I Adult Soft Tissue Sarcoma Stage II Adult Soft Tissue Sarcoma Stage III Adult Soft Tissue Sarcoma Stage IV Adult Soft Tissue Sarcoma Less << Phase 3 Completed - -
NCT00352534 Stage I Wilms Tumor ... More >> Stage II Wilms Tumor Stage III Wilms Tumor Less << Phase 3 Completed - -
NCT00352534 - Completed - -
NCT00845728 - Completed - -
NCT00354627 HIV-1 Phase 3 Completed - -
NCT00354835 - Completed - -
NCT00354835 Adult Malignant Mesenchymoma ... More >> Adult Rhabdomyosarcoma Childhood Alveolar Rhabdomyosarcoma Childhood Botryoid-Type Embryonal Rhabdomyosarcoma Childhood Embryonal Rhabdomyosarcoma Childhood Malignant Mesenchymoma Non-Metastatic Childhood Soft Tissue Sarcoma Stage I Adult Soft Tissue Sarcoma Stage II Adult Soft Tissue Sarcoma Stage III Adult Soft Tissue Sarcoma Untreated Childhood Rhabdomyosarcoma Less << Phase 3 Completed - -
NCT00877383 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - -
NCT00853658 Chronic Heart Failure Phase 3 Completed - -
NCT00879229 Idiopathic Pulmonary Fibrosis ... More >> Pulmonary Hypertension Less << Phase 3 Terminated - -
NCT00868296 - Completed - -
NCT00879229 - Terminated - -
NCT00877383 - Completed - -
NCT00853658 - Completed - -
NCT00868296 Gastroesophageal Reflux Phase 3 Completed - -
NCT00879970 Diabetes Mellitus, Type 2 Phase 4 Terminated(FDA has placed the ... More >>trial on full clinical hold.) Less << - -
NCT00879970 - Terminated(FDA has placed the ... More >>trial on full clinical hold.) Less << - -
NCT00890448 - Completed - -
NCT00379340 Stage III Wilms Tumor With Los... More >>s of Heterozygosity (LOH) for 1p and 16q Stage IV Wilms Tumor Less << Phase 3 Completed - -
NCT00379340 - Completed - -
NCT00891462 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 3 Completed - -
NCT00891462 - Completed - -
NCT00893386 - Completed - -
NCT00388505 Cystic Fibrosis Phase 3 Completed - -
NCT00154336 Rheumatoid Arthritis Phase 2 Completed - Austria ... More >> Novartis Investigative site Graz, Austria, 8036 Novartis Investigative site Vienna, Austria, A-1090 Novartis Investigative site Vienna, Austria, A-1130 Canada, Manitoba Novartis Investigative site Winnipeg, Manitoba, Canada, R3A 1M1 Canada, Ontario Novartis Investigative site Toronto, Ontario, Canada, M5G 1X5 Canada, Quebec Novartis Investigative site Montréal, Quebec, Canada, H3Z 2Z3 Novartis Investigative site Sainte-Foy, Quebec, Canada, G1W 4R4 Finland Novartis Investigative site Helsinki, Finland, 00260 Novartis Investigative site Husu, Finland, 00029 United Kingdom Novartis Investigative site Cannock, Staffordshire, United Kingdom, WS11 2XY Novartis Investigative site Colchester, United Kingdom, CO4 5JL Novartis Investigative site Glasgow, United Kingdom, G11 6NT Novartis Investigative site Manchester, United Kingdom, M41 5SL Multiple Sites Multiple Cities, United Kingdom Novartis Investigative site Stoke-on-Trent, United Kingdom, ST6 7AG Less <<
NCT00391443 Idiopathic Pulmonary Fibrosis Phase 3 Completed - -
NCT00910962 Acute Coronary Syndrome Phase 2 Completed - -
NCT00259038 Heart Failure, Congestive ... More >> Heart Decompensation Left Ventricular Failure Myocardiopathies Systolic or Diastolic Left Ventricular Dysfunction Less << Phase 2 Completed - -
NCT00388505 - Completed - -
NCT00910962 - Completed - -
NCT00391443 - Completed - -
NCT00927186 Osteoporosis, Post-menopausal Phase 4 Completed - United States, Colorado ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lakewood, Colorado, United States, 80227 United States, Georgia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Atlanta, Georgia, United States, 30319 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gainesville, Georgia, United States, 30501 United States, Maryland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bethesda, Maryland, United States, 20817 United States, Michigan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Detroit, Michigan, United States, 48202 United States, Nebraska For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Omaha, Nebraska, United States, 68131 United States, New Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Albuquerque, New Mexico, United States, 87106 United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. West Haverstraw, New York, United States, 10993 United States, Wisconsin For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madison, Wisconsin, United States, 53705 Canada, Alberta For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Calgary, Alberta, Canada, T2N 4Z6 Canada, British Columbia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vancouver, British Columbia, Canada, V6H 3X8 Canada, Quebec For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sainte-Foy, Quebec, Canada, G1V 3M7 Less <<
NCT00957996 Seasonal Influenza ... More >> Cough Sore Throat Nasal Congestion Myalgia Headache Fatigue Less << Phase 3 Completed - -
NCT00412984 Atrial Fibrillation ... More >> Atrial Flutter Less << Phase 3 Completed - -
NCT00419263 Influenza Phase 2 Completed - -
NCT00927186 - Completed - -
NCT00968708 Diabetes Mellitus, Type 2 ... More >> Acute Coronary Syndrome Less << Phase 3 Completed - -
NCT00957996 - Completed - -
NCT00419263 - Completed - -
NCT00425139 Neoplasms Not Applicable Completed - -
NCT00412984 - Completed - -
NCT00445718 - Completed - -
NCT00452400 Pulmonary Disease, Chronic Obs... More >>tructive Asthma Less << Phase 2 Completed - -
NCT01015287 Acute Coronary Syndromes Phase 3 Completed - -
NCT00968708 - Completed - -
NCT00463567 Pulmonary Disease, Chronic Obs... More >>tructive COPD Lung Diseases, Obstructive Less << Phase 2 Phase 3 Completed - -
NCT01015287 - Completed - -
NCT00463567 - Completed - -
NCT00468767 Atrial Fibrillation Phase 3 Completed - -
NCT00467740 - Completed - -
NCT00475852 Heart Decompensation Phase 3 Completed - -
NCT00467740 Asthma Phase 2 Completed - -
NCT00452400 - Completed - -
NCT00475852 - Completed - -
NCT00483743 Copd Bronchitis Phase 2 Completed - Canada, Alberta ... More >> University of alberta Hsopital Edmonton, Alberta, Canada, T6G2B7 Canada, British Columbia Vancouver Hospital Lung Center Vancouver, British Columbia, Canada, V5Z 1 M9 Canada, Ontario Firestone Institute for Respiratory Health Hamilton, Ontario, Canada, L8N4A6 Canada, Quebec Clinique Medical Les Saules Les Saules, Quebec, Canada, G1P 1J6 Omnispec Clinical Research Inc. Mirabel, Quebec, Canada, J7J 2K8 Hopital Thoracique Montreal-CSUM Montreal, Quebec, Canada, H2X2P4 Hopital Sacre Coeur de Montreal Montreal, Quebec, Canada, H4J1C5 Kells Medical Research Group Pointe-Claire, Quebec, Canada, H9R 4S3 Diex Research Inc. Sherbrooke, Quebec, Canada, J1H 1Z1 CHUS -Hopital FLEURIMONT Sherbrooke, Quebec, Canada, J1H5N4 Complexe Medicale Langelier St-Leonard, Quebec, Canada, H1S 3A9 Centre de Cardiologie et de Pneumologie de l'Université Laval Ste-Foy, Quebec, Canada, G1V 4G5 Canada, Saskatchewan Royal University Hospital Saskatoon, Saskatchewan, Canada, S7N 0W8 Less <<
NCT00500318 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - -
NCT00327691 Cardiovascular Disease ... More >> Cerebrovascular Accident Coronary Heart Disease Less << Phase 4 Completed - -
NCT01077362 - Completed - -
NCT00500318 - Completed - -
NCT01035255 Heart Failure With Reduced Eje... More >>ction Fraction Less << Phase 3 Terminated(Early termination w... More >>as approved due to compelling efficacy of LCZ696 in patients with HF & reduced EF after final pre-specified interim analysis 28-Mar-2014.) Less << - -
NCT01035255 - Terminated(Early termination w... More >>as approved due to compelling efficacy of LCZ696 in patients with HF & reduced EF after final pre-specified interim analysis 28-Mar-2014.) Less << - -
NCT00513370 Psoriasis Phase 3 Completed - Canada, Alberta ... More >> Calgary, Alberta, Canada, T2S 3B3 Calgary, Alberta, Canada, T3A 2N1 Edmonton, Alberta, Canada, T5K 1X3 Canada, British Columbia Surrey, British Columbia, Canada, V3R 6A7 Vancouver, British Columbia, Canada, V5Z 4E8 Canada, Manitoba Winnipeg, Manitoba, Canada, R3C 0N2 Winnipeg, Manitoba, Canada, R3C 1R4 Canada, New Brunswick Moncton, New Brunswick, Canada, E1C 8X3 Canada, Newfoundland and Labrador St. John's, Newfoundland and Labrador, Canada, A1B 3E1 St. John's, Newfoundland and Labrador, Canada, A1C 2H5 Canada, Nova Scotia Halifax, Nova Scotia, Canada, B3H 1Z4 Canada, Ontario Barrie, Ontario, Canada, L4M 6L2 Fenwick, Ontario, Canada, L0S 1C0 Hamilton, Ontario, Canada, L8N 1V6 London, Ontario, Canada, N5X 2P1 London, Ontario, Canada, N6A 3H7 Markham, Ontario, Canada, L3P 1A8 Nepean, Ontario, Canada, K2G 6E2 North Bay, Ontario, Canada, P1B 3Z7 Oakville, Ontario, Canada, L6J 7W5 Oakville, Ontario, Canada, L6K 1E1 Toronto, Ontario, Canada, M4V 1R1 Waterloo, Ontario, Canada, N2J 1C4 Canada, Quebec Montreal, Quebec, Canada, H3Z 2S6 Sherbrooke, Quebec, Canada, J1H 1Z1 Ste-Foy, Quebec, Canada, G1V 4X7 Canada Quebec, Canada, G1J 1X7 Less <<
NCT00513370 - Completed - -
NCT01077362 Arthritis, Psoriatic Phase 3 Completed - -
NCT01080131 - Completed - -
NCT01080131 Acute Gout Phase 3 Completed - -
NCT01087762 Spondyloarthropathies Phase 3 Completed - -
NCT00523978 Paroxysmal Atrial Fibrillation Phase 3 Completed - -
NCT00523978 - Completed - -
NCT00529529 Asthma Phase 3 Completed - -
NCT00523991 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 4 Completed - -
NCT00549770 Hypertension Phase 2 Completed - -
NCT00559650 Congestive Heart Failure Phase 2 Terminated - -
NCT01087762 - Completed - -
NCT00549770 - Completed - -
NCT01144338 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00571649 Venous Thromboembolism Phase 3 Completed - -
NCT01172938 Psoriatic Arthritis Phase 3 Completed - -
NCT01168973 - Completed - -
NCT00523991 - Completed - -
NCT01172938 - Completed - -
NCT00571649 - Completed - -
NCT01168973 Non-Small Cell Lung Cancer Phase 3 Completed - -
NCT00608023 - Completed - -
NCT01194414 Rheumatoid Arthritis Phase 3 Completed - -
NCT01144338 - Completed - -
NCT00529529 - Completed - -
NCT01194414 - Completed - -
NCT00608023 Lipodystrophy ... More >> HIV Infections Less << Phase 3 Completed - -
NCT01209702 Spondylitis, Ankylosing Phase 3 Terminated(Recruitment halted ... More >>Failed to achieve efficacy) Less << - -
NCT01209702 - Terminated(Recruitment halted ... More >>Failed to achieve efficacy) Less << - -
NCT00267969 Psoriasis Phase 3 Completed - -
NCT00267969 - Completed - -
NCT00268216 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - -
NCT00269230 Heart Failure Not Applicable Completed - -
NCT00005971 Melanoma (Skin) Phase 2 Completed - -
NCT00273026 Asthma Phase 4 Terminated - -
NCT00271544 - Completed - -
NCT00280423 Sleep Initiation and Maintenan... More >>ce Disorders Insomnia Less << Phase 2 Completed - -
NCT00271544 Heart Failure Not Applicable Completed - -
NCT00279045 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00003352 Breast Cancer Phase 2 Completed - -
NCT00273195 Ventricular Arrhythmias Not Applicable Completed - -
NCT00291330 Thromboembolism Phase 3 Completed - -
NCT00292552 - Completed - -
NCT00298896 Carcinoma, Small Cell ... More >> Small Cell Lung Cancer Less << Phase 2 Completed - United States, California ... More >> University of California Davis Sacramento, California, United States, 95817 Stanford University Medical Center Stanford, California, United States, 94305 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Baltimore, Maryland, United States, 21231 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 The Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Canada, Alberta Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BC Cancer Agency Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Canada, Quebec Hopital Charles LeMoyne Greenfield Park, Quebec, Canada, J4V 2H1 Hopital Laval Sainte-Foy, Quebec, Canada, G1V 4G5 Less <<
NCT00284830 Sick Sinus Syndrome ... More >> Heart Failure, Congestive Atrial Fibrillation Bradycardia Ventricular Dysfunction Less << Not Applicable Completed - -
NCT00006453 Ovarian Cancer Phase 3 Completed - -
NCT00299546 Arthritis, Rheumatoid Phase 3 Completed - -
NCT00300274 Graft Rejection Phase 3 Completed - -
NCT00291330 - Completed - -
NCT00299546 - Completed - -
NCT00281593 Hypertension Phase 3 Completed - -
NCT00066313 Lung Cancer Phase 2 Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre - Calgary Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute at University of Alberta Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia British Columbia Cancer Agency - Centre for the Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 Fraser/Valley Cancer Centre at British Columbia Cancer Agency Surrey, British Columbia, Canada, V3V 1Z2 British Columbia Cancer Agency - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, New Brunswick Moncton Hospital Moncton, New Brunswick, Canada, E1C 6ZB Saint John Regional Hospital Saint John, New Brunswick, Canada, E2L 4L2 Canada, Ontario Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Cancer Centre of Southeastern Ontario at Kingston General Hospital Kingston, Ontario, Canada, K7L 5P9 Ottawa Hospital Regional Cancer Centre - General Campus Ottawa, Ontario, Canada, K1H 8L6 St. Catharines General Hospital at Niagara Health System St. Catharines, Ontario, Canada, L2R 5K3 Northwestern Ontario Regional Cancer Care at Thunder Bay Regional Health Sciences Centre Thunder Bay, Ontario, Canada, P7B 6V4 Toronto East General Hospital Toronto, Ontario, Canada, M4C 3E7 Toronto Sunnybrook Regional Cancer Centre at Sunnybrook and Women's College Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 Mount Sinai Hospital - Toronto Toronto, Ontario, Canada, M5G 1X5 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Windsor Regional Cancer Centre at Windsor Regional Hospital Windsor, Ontario, Canada, N8W 2X3 Canada, Quebec Hopital Notre- Dame du CHUM Montreal, Quebec, Canada, H2L 4M1 McGill Cancer Centre at McGill University Montreal, Quebec, Canada, H2W 1S6 L'Hopital Laval Ste-Foy, Quebec, Canada, G1V 4G5 Canada, Saskatchewan Saskatoon Cancer Centre at the University of Saskatchewan Saskatoon, Saskatchewan, Canada, S7N 4H4 Less <<
NCT00031707 Anorexia Cach... More >>exia Less << Phase 3 Completed - -
NCT00298896 - Completed - -
NCT00067236 Myocardial Infarction ... More >> Heart Failure Heart Enlargement Less << Phase 2 Completed - -
NCT00066898 Atherosclerosis ... More >> Coronary Artery Disease Myocardial Infarction Unstable Angina Less << Phase 3 Unknown - -
NCT00306787 Genital Herpes Phase 3 Completed - -
NCT00066482 Childhood Germ Cell Tumor ... More >> Extragonadal Germ Cell Tumor Less << Not Applicable Completed - -
NCT00300274 - Completed - -
NCT00307437 Psoriasis Phase 3 Completed - -
NCT00319111 Pulmonary Hypertension Phase 3 Completed - -
NCT00306787 - Completed - -
NCT00070174 Leukemia Phase 2 Completed - -
NCT00319111 - Completed - -
NCT00003594 Colorectal Cancer Phase 3 Completed - -
NCT00328172 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT00067236 - Completed - -
NCT00343252 Osteoporosis, Postmenopausal ... More >> Back Pain Spinal Fracture Less << Phase 3 Completed - -
NCT00328172 - Completed - -
NCT00307437 - Completed - -
NCT00144833 HIV-1 Phase 3 Terminated(Incomplete data) - -
NCT00343252 - Completed - -
NCT00333411 Psoriasis Phase 2 Completed - -
NCT00355849 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00168792 Myocardial Infarction Phase 4 Terminated - -
NCT00347412 Non Small Cell Lung Cancer Phase 3 Completed - -
NCT00362609 - Completed - -
NCT00362609 Gastroesophageal Reflux Phase 3 Completed - -
NCT00075582 Adult Rhabdomyosarcoma ... More >> Embryonal Childhood Rhabdomyosarcoma Embryonal-botryoid Childhood Rhabdomyosarcoma Previously Untreated Childhood Rhabdomyosarcoma Less << Phase 3 Unknown - -
NCT00369382 Graft Rejection ... More >> Kidney Failure Less << Phase 4 Completed - United States, Florida ... More >> Pfizer Investigational Site Tampa, Florida, United States, 33606 United States, Minnesota Pfizer Investigational Site Rochester, Minnesota, United States, 55905 United States, New York Pfizer Investigational Site New York, New York, United States, 10027-6902 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19102 Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19104 Pfizer Investigational Site Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Pfizer Investigational Site Houston, Texas, United States, 77030 United States, Virginia Pfizer Investigational Site Norfolk, Virginia, United States, 23507 Australia, New South Wales Pfizer Investigational Site Darlinghurst, New South Wales, Australia, 2010 Austria Pfizer Investigational Site Vienna, Austria, A-1090 Canada, Quebec Pfizer Investigational Site Montreal, Quebec, Canada, H1T 1C8 Pfizer Investigational Site Sainte-Foy, Quebec, Canada, G1V 4G5 Canada Pfizer Investigational Site Quebec, Canada, G1V 4G5 New Zealand Pfizer Investigational Site Epsom, Auckland, New Zealand, 1003 Pfizer Investigational Site Auckland, New Zealand Spain Pfizer Investigational Site L'Hospitalet de Llobregat, Barcelona, Spain, 08907 Pfizer Investigational Site Santander, Cantabria, Spain, 39008 Pfizer Investigational Site Barcelona, Spain, 08036 Pfizer Investigational Site La Coru?a, Spain, 15001 Pfizer Investigational Site Madrid, Spain, 28035 Pfizer Investigational Site Sevilla, Spain, 41013 Pfizer Investigational Site Valencia, Spain, 46009 Switzerland Pfizer Investigational Site Bern, Switzerland, 3010 Less <<
NCT00169832 Diabetes Coro... More >>nary Artery Bypass Grafting Less << Phase 3 Completed - Canada, Nova Scotia ... More >> QEII Health Sciences Center - Halifax Infirmary Halifax, Nova Scotia, Canada, B3H 3A7 Canada, Ontario Hamilton Health Sciences - Mc Master Clinic Hamilton, Ontario, Canada, L8L 2X2 Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Canada, Quebec CRMSBC Bonaventure, Quebec, Canada, G0C 1E0 CHUM Notre-Dame Hospital Montreal, Quebec, Canada, H2L 4M1 Laval Hospital Sainte-Foy, Quebec, Canada, G1V 4G5 Spain Hospital Del Mar Barcelona, Spain Hospital Universitari Vall D'Hebron Barcelona, Spain Hospital Universitarion Son Dureta Palma de Mallorca, Spain Less <<
NCT00371774 - Completed - Canada, Alberta ... More >> Calgary, Alberta, Canada, T2S 3B3 Calgary, Alberta, Canada, T3A 2N1 Edmonton, Alberta, Canada, T5J 3S9 Edmonton, Alberta, Canada, T5K 1X3 Canada, British Columbia Surrey, British Columbia, Canada, V3R6A7 Vancouver, British Columbia, Canada, V5Z 3Y1 Vancouver, British Columbia, Canada, V5Z 4E8 Victoria, British Columbia, Canada, V8V 3P9 Victoria, British Columbia, Canada, V8V 4X3 Canada, Manitoba Winnipeg, Manitoba, Canada, R3C 1R4 Canada, New Brunswick Moncton, New Brunswick, Canada, E1C 8X3 Saint John, New Brunswick, Canada, E2M 3W5 Canada, Newfoundland and Labrador St John's, Newfoundland and Labrador, Canada, A1B 3A1 St. John's, Newfoundland and Labrador, Canada, A1B 3E1 St. John's, Newfoundland and Labrador, Canada, A1B 4S8 Canada, Nova Scotia Halifax, Nova Scotia, Canada, B3H 124 Canada, Ontario Barrie, Ontario, Canada, L7M 6L7 Concord, Ontario, Canada, L4K 5V2 Hamilton, Ontario, Canada, L8N 3H7 London, Ontario, Canada, N6A 3H7 London, Ontario, Canada, N6H 1S9 Markham, Ontario, Canada, L3P 1A8 Oakville, Ontario, Canada, L6K 1E1 Toronto, Ontario, Canada, M5S 1B6 Waterloo, Ontario, Canada, N2J 1C4 Windsor, Ontario, Canada, N8W 5L7 Canada, Quebec Montreal, Quebec, Canada, H2K 4L5 Montreal, Quebec, Canada, H3G 1A1 Sainte-Foy, Quebec, Canada, G1V 4X7 Canada Quebec, Canada, G1J 1X7 Less <<
NCT00369382 - Completed - -
NCT00003011 Lung Cancer Phase 3 Completed - -
NCT00076388 Non-Small-Cell Lung Carcinoma Phase 3 Completed - -
NCT00006890 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - -
NCT00078988 Brain Tumor C... More >>entral Nervous System Tumor Less << Phase 3 Completed - -
NCT00258713 Psoriasis Phase 3 Completed - Canada, Alberta ... More >> Isotechnika Investigational Site Calgary, Alberta, Canada, T2S 3B3 Isotechnika Investigational Site Edmonton, Alberta, Canada, T5J 3S9 Canada, British Columbia Isotechnika Investigational Site Vancouver, British Columbia, Canada, V5Z 3Y1 Isotechnika Investigational Site Vancouver, British Columbia, Canada, V5Z 4E8 Canada, Manitoba Isotechnika Investigational Site Winnipeg, Manitoba, Canada, R3C 0N2 Canada, New Brunswick Isotechnika Investigational Site Moncton, New Brunswick, Canada, E1C 8X3 Canada, Newfoundland and Labrador Isotechnika Investigational Site St. John's, Newfoundland and Labrador, Canada, A1B 3E1 Isotechnika Investigational Site St. John's, Newfoundland and Labrador, Canada, A1B 4F8 Canada, Nova Scotia Isotechnika Investigational Site Halifax, Nova Scotia, Canada, B3H 1Z4 Canada, Ontario Isotechnika Investigational Site Barrie, Ontario, Canada, L4M 6L2 Isotechnika Investigational Site Hamilton, Ontario, Canada, L8N 1V6 Isotechnika Investigational Site London, Ontario, Canada, N5X 2P1 Isotechnika Investigational Site London, Ontario, Canada, N6A 3H7 Isotechnika Investigational Site Maple, Ontario, Canada, L4K 5V2 Isotechnika Investigational Site Markham, Ontario, Canada, L3P 1A8 Isotechnika Investigational Site Newmarket, Ontario, Canada, L3Y 6P5 Isotechnika Investigational Site North Bay, Ontario, Canada, P1B 3Z7 Isotechnika Investigational Site Oakville, Ontario, Canada, L6K 1E1 Isotechnika Investigational Site Oshawa, Ontario, Canada, L1H 1B9 Isotechnika Investigational Site Waterloo, Ontario, Canada, N2J 1C4 Isotechnika Investigational Site Windsor, Ontario, Canada, N8W 1E6 Isotechnika Investigational Site Windsor, Ontario, Canada, N8W 5L7 Canada, Quebec Isotechnika Investigational Site Laval, Quebec, Canada, H7G 2C6 Isotechnika Investigational Site Montreal, Quebec, Canada, H2K 4L5 Isotechnika Investigational Site Montreal, Quebec, Canada, H3G 1C6 Isotechnika Investigational Site Montreal, Quebec, Canada, H3H 1V4 Isotechnika Investigational Site Pointe Claire, Quebec, Canada, H9R 4S3 Isotechnika Investigational Site Saint Foy, Quebec, Canada, G1V 4X7 Isotechnika Investigational Site Sherbrooke, Quebec, Canada, J1J 2B8 Less <<
NCT00400946 Drug/Agent Toxicity by Tissue/... More >>Organ Leukemia Less << Phase 3 Active, not recruiting June 2019 United States, Massachusetts ... More >> Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Albert Einstein Cancer Center at Albert Einstein College of Medicine Bronx, New York, United States, 10461 Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Rhode Island Hasbro Children's Hospital Providence, Rhode Island, United States, 02903 United States, Virginia INOVA Fairfax Hospital Fairfax, Virginia, United States, 22031 Canada, Ontario McMaster Children's Hospital at Hamilton Health Sciences Hamilton, Ontario, Canada, L8N 3Z5 Canada, Quebec Hopital Sainte Justine Montreal, Quebec, Canada, H3T 1C5 Centre de Recherche du Centre Hospitalier de l'Universite Laval Sainte Foy, Quebec, Canada, GIV 4G2 Puerto Rico San Jorge Children's Hospital Santurce, Puerto Rico, 00912 Less <<
NCT00400946 - Active, not recruiting - -
NCT00075582 - Unknown - -
NCT00002583 Lung Cancer Phase 3 Completed - -
NCT00409188 Non-small Cell Lung Cancer Phase 3 Completed - -
NCT00282971 - Terminated(Terminated as marke... More >>ting of this product will be discontinued) Less << - -
NCT00005974 Sarcoma Phase 2 Completed - -
NCT00282971 Diabetes Mellitus Type 2 Phase 3 Terminated(Terminated as marke... More >>ting of this product will be discontinued) Less << - -
NCT00433654 Bradycardia S... More >>low Heart Beat Less << Not Applicable Completed - -
NCT00002707 Breast Cancer Phase 3 Completed - -
NCT00409188 - Completed - -
NCT00433654 - Completed - -
NCT00003892 Ovarian Cancer Phase 2 Completed - -
NCT00452348 Asthma Phase 4 Completed - -
NCT00002864 Breast Cancer Phase 3 Completed - -
NCT00479739 Asthma Phase 4 Completed - -
NCT00442845 Coronary Arteriosclerosis ... More >> Diabetes Mellitus, Type 2 Cerebrovascular Accident Dyslipidemia Peripheral Vascular Disease Less << Phase 4 Completed - -
NCT00095030 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00094302 - Completed - -
NCT00095147 Rheumatoid Arthritis Phase 3 Completed - -
NCT00095238 Congestive Heart Failure Phase 3 Completed - -
NCT00095394 Hypertension Phase 3 Completed - -
NCT00095147 - Completed - -
NCT00394199 Asthma Phase 3 Completed - -
NCT00452348 - Completed - -
NCT00500955 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00106366 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00095238 - Completed - -
NCT00094302 Cardiovascular Diseases ... More >> Heart Diseases Heart Failure, Congestive Less << Phase 3 Completed - -
NCT00558285 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 2 Completed - -
NCT00097357 Venous Thrombosis ... More >> Pulmonary Embolism Less << Phase 2 Phase 3 Completed - -
NCT00558428 Hypertension Phase 3 Completed - -
NCT02951429 Idiopathic Pulmonary Fibrosis Phase 2 Active, not recruiting August 29, 2020 -
NCT00559910 Chronic Obstructive Pulmonary ... More >>Disease Less << Phase 2 Completed - -
NCT00558285 - Completed - -
NCT00107198 - Unknown - -
NCT00558428 - Completed - -
NCT00565812 Osteoarthritis Phase 2 Completed - -
NCT00107198 Childhood Lymphocyte Predomina... More >>nt Hodgkin Lymphoma Stage I Childhood Hodgkin Lymphoma Stage II Childhood Hodgkin Lymphoma Less << Not Applicable Unknown - -
NCT00600171 Asthma Phase 2 Completed - -
NCT00600171 - Completed - -
NCT00575796 Glioma Phase 2 Active, not recruiting October 2019 Canada, Alberta ... More >> Alberta Children's Hospital Calgary, Alberta, Canada, T3B 6A8 Stollery Children's Hospital Edmonton, Alberta, Canada, T6G 2J3 Canada, British Columbia Children's and Women's Health Centre of British Columbia Vancouver, British Columbia, Canada, V6H 3V4 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Newfoundland and Labrador Janeway Child Health Centre St. John's, Newfoundland and Labrador, Canada, A1B 3V6 Canada, Nova Scotia IWK Health Centre Halifax, Nova Scotia, Canada, B3K 6R8 Canada, Ontario McMaster University Hamilton, Ontario, Canada, L8S 4J9 Kingston General Hospital Kingston, Ontario, Canada, K7L 2V7 Children's Hospital of Western Ontario London, Ontario, Canada, N6C 2V5 Children's Hospital of Eastern Ontario Ottawa, Ontario, Canada, K1H 8L1 The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Canada, Quebec Montreal Children's Hospital Montreal, Quebec, Canada, H3H 1P3 Hospital Sainte-Justine Montreal, Quebec, Canada, H3T 1C5 Centre Hospitalier Universitaire de Quebec Sainte-Foy, Quebec, Canada, G1V 4G2 Centre Hospitalier Universitaire de Sherbrooke Sherbrooke, Quebec, Canada, J1H 5N4 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Saskatoon Cancer Center Saskatoon, Saskatchewan, Canada, S7N 4H4 Less <<
NCT00603278 Asthma Phase 2 Completed - -
NCT00603382 Asthma Phase 2 Completed - -
NCT00603382 - Completed - -
NCT00108095 Postoperative Nausea and Vomit... More >>ing Nausea and Vomiting, Postoperative Less << Phase 2 Completed - -
NCT00603278 - Completed - -
NCT00614380 Hypertension Phase 3 Completed - -
NCT00603746 Asthma Phase 2 Completed - -
NCT00565812 - Completed - -
NCT00577837 Postmenopausal Phase 2 Completed - United States, Florida ... More >> Research Site Daytona Beach, Florida, United States Research Site Gainesville, Florida, United States United States, Kansas Research Site Shawnee Mission, Kansas, United States United States, Texas Research Site San Antonio, Texas, United States Canada, Ontario Research Site Hamilton, Ontario, Canada Canada, Quebec Research Facility Montreal, Quebec, Canada Research Facility Sainte-Foy, Quebec, Canada Croatia Research Facility Zagreb, Croatia Netherlands Research Facility Amsterdam, Netherlands Research Facility Leiden, Netherlands Poland Research Facility Bialystok, Poland Research Site Lublin, Poland Research Site Warszawa, Poland Research Site Wroclaw, Poland Less <<
NCT00614380 - Completed - -
NCT03099187 Lung Diseases, Interstitial Phase 2 Active, not recruiting January 14, 2020 -
NCT00121641 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00643565 Sarcoma Phase 2 Active, not recruiting April 30, 2019 -
NCT00603746 - Completed - -
NCT00121641 - Completed - -
NCT00134485 Hypercholesterolemia, Familial... More >> Hyperlipidemia Less << Phase 3 Completed - -
NCT00647270 - Completed - -
NCT00137605 Pneumococcal Infections Phase 1 Phase 2 Completed - Canada, British Columbia ... More >> Medical Arts Health Research Group Kelowna, British Columbia, Canada, V1Y 1T2 Downtown IDC Vancouver, British Columbia, Canada St. Paul's Hospital Vancouver, British Columbia, Canada Canada, Manitoba St. Boniface General Hospital Winnipeg, Manitoba, Canada Canada, New Brunswick Moncton Hospital Windsor, New Brunswick, Canada Canada, Nova Scotia Victoria General Halifax, Nova Scotia, Canada Canada, Ontario McMaster University Hamilton, Ontario, Canada St. Joseph's Hospital London, Ontario, Canada Sunnybrook Toronto, Ontario, Canada Toronto General Toronto, Ontario, Canada Metropolitan Hospital Windsor, Ontario, Canada Canada, Quebec Montreal Chest/Royal-Victoria Montreal, Quebec, Canada Centre Hospitalier Universitaire de Sherbrooke Sherbrooke, Quebec, Canada Centre Hospitalier Universitaire de Laval Ste-Foy, Quebec, Canada Less <<
NCT00134498 Hypertriglyceridemia ... More >> Hyperlipoproteinemia Type IV Less << Phase 3 Completed - -
NCT00643565 - Active, not recruiting - -
NCT00138658 Non-small Cell Lung Cancer Phase 1 Phase 2 Completed - United States, California ... More >> LAC-USC Medical Center Los Angeles, California, United States, 90033 University of Southern California Norris Los Angeles, California, United States, 90033 United States, New York New York Oncology Hematology Albany, New York, United States, 12208 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, South Carolina Cancer Centers of the Carolinas Greenville, South Carolina, United States, 29605 United States, Texas Mary Crowley Medical Research Center Dallas, Texas, United States, 75246 Canada, Alberta Tom Baker Cancer Centre Calgary, Alberta, Canada Canada, British Columbia BC Cancer Agency, Fraser Valley Centre Surrey, British Columbia, Canada BC Cancer Agency, Vancouver Center Vancouver, British Columbia, Canada Canada, Newfoundland and Labrador Dr. H. Bliss Murphy Cancer Center St. Johns, Newfoundland and Labrador, Canada Canada, Ontario Royal Victoria Hospital of Barrie Barrie, Ontario, Canada London Regional Cancer Centre London, Ontario, Canada Ottawa Hospital Ottawa, Ontario, Canada Toronto Sunnybrook Regional Cancer Center Toronto, Ontario, Canada Canada, Quebec Hopital Laval Ste-Foy, Quebec, Canada Less <<
NCT00658606 - Completed - -
NCT00647270 Rheumatoid Arthritis Phase 3 Completed - -
NCT00658606 Plaque Psoriasis Phase 4 Completed - Canada, Alberta ... More >> Calgary, Alberta, Canada, T2S 3B3 Canada, British Columbia Surrey, British Columbia, Canada, V3R 6A7 Vancouver, British Columbia, Canada, V5Z 4E8 Canada, Newfoundland and Labrador St. John's, Newfoundland and Labrador, Canada, A1C 2H5 Canada, Ontario London, Ontario, Canada, N5X 2P1 Markham, Ontario, Canada, L3P 1A8 Toronto, Ontario, Canada, M5S 1B6 Canada, Quebec Montreal, Quebec, Canada, H2K 4L5 Montreal, Quebec, Canada, H3H 1V4 Sainte-Foy, Quebec, Canada, G1V 4X7 Canada, Saskatchewan Saskatoon, Saskatchewan, Canada, S7N 0W8 Canada Quebec, Canada, G1J 1X7 Less <<
NCT00141102 Osteoarthritis ... More >> Arthritis, Rheumatoid Less << Phase 4 Completed - -
NCT00143728 HIV Infections Phase 4 Suspended(Enrollment.) May 2010 Canada, British Columbia ... More >> Downtown IDC Vancouver, British Columbia, Canada Cool Aid Community Health Centre Victoria, British Columbia, Canada Canada, Manitoba St. Boniface General Hospital Winnipeg, Manitoba, Canada Canada, Ontario McMaster University Hamilton, Ontario, Canada Haven Program Sudbury, Ontario, Canada Maple Leaf Clinic Toronto, Ontario, Canada Sunnybrook Hospital Toronto, Ontario, Canada Canada, Quebec Montreal General Hospital Montreal, Quebec, Canada Centre Hospitalier de l'université de Laval Ste-Foy, Quebec, Canada Less <<
NCT00138658 - Completed - -
NCT00151788 Atherosclerosis ... More >> Heterozygous Familial Hypercholesterolemia Less << Phase 2 Phase 3 Terminated - -
NCT00139776 - Completed - -
NCT00662597 Non-Small Cell Lung Cancer Phase 3 Terminated - -
NCT00152984 Pulmonary Disease, Chronic Obs... More >>tructive Asthma Less << Phase 4 Completed - -
NCT00139776 Osteoarthritis, Knee ... More >> Osteoarthritis, Hip Less << Phase 4 Completed - -
NCT00159640 Pain Phase 2 Terminated - -
NCT00163202 Coronary Arteriosclerosis ... More >> Hypercholesterolemia Less << Phase 4 Completed - -
NCT00141102 - Completed - -
NCT00153101 Cardiovascular Diseases Phase 4 Completed - -
NCT00162266 - Completed - -
NCT00667823 Pulmonary Arterial Hypertensio... More >>n Less << Phase 3 Active, not recruiting September 15, 2021 -
NCT00162266 Rheumatoid Arthritis Phase 2 Completed - -
NCT00153101 - Completed - -
NCT00561925 HIV Infections Phase 3 Completed - -
NCT00440271 HIV Infections Phase 3 Terminated - -
NCT00704847 Osteoarthritis Phase 3 Terminated(Male subjects were ... More >>terminated due to an imbalance in prostate cancer events) Less << - United States, Alabama ... More >> Achieve Clinical Research, LLC Tuscaloosa, Alabama, United States, 35406 United States, California Center for Healthy Aging Sacramento, California, United States, 95817 United States, Illinois Northwestern Center for Clinical Research Chicago, Illinois, United States, 60611 United States, Missouri Midwest Pharmaceutical Research St. Peters, Missouri, United States, 63376 United States, North Carolina Thurston Arthritis Research Center Chapel Hill, North Carolina, United States, 27599 United States, Ohio Rheumatology Clinical Research Unit Beachwood, Ohio, United States, 44122 Belgium Hospital Universitaire St. Luc, UCL 5390 Brussels, Belgium, 1200 Canada Centre de Rhumatologie St-Louis Sainte-Foy (Québec), Canada, G1W 4R4 Czech Republic CCBR Czech Pardubice, Czech Republic, 53002 Denmark CCBR Aalborg Aalborg, Denmark, 9000 CCBR Ballerup Ballerup, Denmark, 2750 CCBR Vejle Vejle, Denmark, 7100 Hong Kong CCBR Hong Kong Hong Kong, Hong Kong Poland Centrum Osteoporozy i Chorób Kostno Stawowych, ul. Waryńskiego 6/2 Bialystok, Poland, 15-461 CCBR Poland Warsaw, Poland, 04703 Romania CCBR Romania Bucharest, Romania, 030463 Spain Hospital Universitario de la Paz Madrid, Spain, 28046 United Kingdom Little Common Surgery East Sussex, United Kingdom, TN 39 4SP Less <<
NCT00671684 Chronic Constipation ... More >> Hirschsprung's Disease Less << Phase 1 Phase 2 Unknown April 2009 United States, Massachusetts ... More >> Massachusetts General Hosptial Boston, Massachusetts, United States, 02114 Less <<
NCT00561925 - Completed - -
NCT00268398 Colorectal Cancer ... More >> Metastatic Cancer Chemotherapy Less << Phase 3 Completed - France ... More >> Institut Sainte Catherine Avignon, France, 84000 Hopital Duffaut Avignon, France, 84902 C.H.G. Beauvais Beauvais, France, 60021 Hopital Saint Andre Bordeaux, France, 33075 Centre Hospitalier Docteur Duchenne Boulogne Sur Mer, France, 62200 Hopital Ambroise Pare Boulogne-Billancourt, France, F-92104 Centre Hospitalier de Briey Briey, France, 54151 Centre Regional Francois Baclesse Caen, France, 14076 Hopital Louis Pasteur Chartres, France, 28018 Hopital Beaujon Clichy, France, 92118 Louis Mourier Hospital Colombes Cedex, France, 92701 Clinique du Parc Croix, France, 59170 Hopital Drevon Dijon, France, 21000 Centre Hospitalier Departemental La Roche Sur Yon, France, F-85025 Hopital Saint - Louis La Rochelle, France, 17000 Hopital Robert Boulin Libourne, France, 33500 Polyclinique Du Bois Lille, France, 59000 Centre Hospital Universitaire Hop Huriez Lille, France, 59037 Polyclinique des Quatre Pavillons Lormont, France, 33310 Hopital Saint Joseph Marseille, France, 13008 Hopital Notre-Dame de Bon Secours Metz, France, 57038 Centre Hospitalier Intercommunal Le Raincy - Montfermeil Montfermeil, France, 93370 Hopital Europeen Georges Pompidou Paris, France, 75015 Hopital Saint Antoine Paris, France, 75571 CHU Pitie-Salpetriere Paris, France, 75651 Hopital Tenon Paris, France, 75970 Hopital Haut Leveque Pessac, France, 33604 Polyclinique De Courlancy Reims, France, F-51100 Clinique Specialise du Littoral-Cote d'Opale Saint Martin Boulogne, France, 62280 Clinique Charcot Sainte Foy Les Lyon, France, 69110 C.H. Senlis Senlis, France, 60309 Hopital Foch Suresnes, France, 92151 Less <<
NCT00112658 Pancreatic Cancer Phase 2 Phase 3 Unknown - -
NCT00195650 Rheumatoid Arthritis Phase 3 Completed - -
NCT00440271 - Terminated - -
NCT00163436 Asthma Phase 3 Completed - -
NCT00195650 - Completed - -
NCT01039402 - Completed - -
NCT00313209 - Completed - -
NCT00420927 Rheumatoid Arthritis Phase 4 Completed - -
NCT00313209 Chronic Obstructive Pulmonary ... More >>Disease (COPD) Less << Phase 3 Completed - -
NCT00420927 - Completed - -
NCT01459653 - Completed - -
NCT00704847 - Terminated(Male subjects were ... More >>terminated due to an imbalance in prostate cancer events) Less << - -
NCT00770250 - Completed - -
NCT01459653 - Completed - -
NCT00560768 Sudden Cardiac Death Phase 4 Completed - United States, Alabama ... More >> Helen Kelle Hospital Sheffield, Alabama, United States, 35660 United States, California Valley Regional Arrhytmia Center Tarzana, California, United States, 91356 United States, Georgia Piedmont Hospital Atlanta, Georgia, United States, 30309 United States, North Carolina CMC - NorthEast Charlotte, North Carolina, United States, 28025 United States, Ohio Northwest Ohio Cardiology Consultants Toledo, Ohio, United States, 43615 United States, Pennsylvania Stafford M. Smith - Scranton Heart Institute Clarks Green, Pennsylvania, United States, 18411-2326 Easton Cardiology Easton, Pennsylvania, United States, 18042 Canada Grey-Nuns Hospital Edmonton, Canada, X0C0B0 Hotel-Dieu du CHUM Montreal, Canada, H2W1T8 Laval UH, Ste Foy Quebec, Canada, G1V4G5 St. Michael's Hospital Toronto, Canada, M5B1W8 Germany Herz-und Diabeteszentrum NRW Bad Oeynhausen, Germany, D-32545 Praxis Westend Berlin, Germany, 10050 Universitatsklinik Krankenanstalten Bergmannsheil Bochum, Germany, 44789 Medizinische Universitatsklinik Bonn, Germany, D-53127 Klinikum Coburg, Germany, 96450 Landkrankhenhaus Coburg Coburg, Germany, 96450 Evangelisches Krankenhaus Dusseldorf, Germany, 40217 Evangelisches Krankhenhaus Düsseldorf Düsseldorf, Germany, 40217 Kardiocentrum Frankfurt, Germany, 60316 Kardiocentrum Frankfurt, Klinik Rotes Kreuz Frankfurt, Germany, D-60316 Städt Klinikum Lüneburg Lüneburg, Germany, 21339 Johannes Gutenberg-Universitat Mainz, Germany, 55101 Universitatklinikum Mainz Mainz, Germany, D-55101 Bogenhausen Städt. Krankenhaus München, Germany, 81925 Krankenhaus Reinbeck St Adolf-Stift Reinbeck, Germany, 21465 ST. Adolf Stift; Medizinische Klinik Reinbek, Germany, 21465 Medizinische Klinik und Poliklinik I / kardiologie Wurzburg, Germany, D-97080 Universitätsklinikum Würzburg Würzburg, Germany, 97080 Spain Universitario La Fe Valencia, Spain, 46009 Less <<
NCT00939003 Axial Spondyloarthritis Phase 3 Completed - -
NCT00695838 - Completed - -
NCT01207115 Osteoarthritis of the Knee Phase 2 Completed - -
NCT00427375 Rectal Neoplasms Phase 3 Completed - France ... More >> Centre Radiothérapie Oncologie Moyenne Garonne - 13 Quai du Docteur Calabet Agen, France, 47000 Polyclinique Sainte marguerite Auxerre, France, 89000 Service de Chirurgie Viscérale, Digestive et Cancérologique - CHRU J.Minoz - Boulevard Fleming Besançon, France, 25030 Service de Radiothérapie - Clinique Tivoli - 220 rue Mandron Bordeaux, France, 33000 Service de chirurgie digestive - hôpital Saint André - 1 rue Jean Burguet Bordeaux, France, 33075 Service de Chirurgie Oncologique - Institut Bergonié - 229, cours de l'Argonne Bordeaux, France, 33076 Service de Chirurgie Digestive - Hôpital ambroise Paré - 9 avenue Charles de Gaulle Boulogne Billancourt, France, 92100 Service de Chirurgie Générale et Digestive - Hôtel Dieu - CHU Clermont-Ferrand - Boulevard Léon Malfreyt Clermont-Ferrand, France, 63000 Département de Radiothérapie - Centre Jean Perrin - 58 rue Montalembert Clermont-Ferrand, France, 63011 Service de Chirurgie Générale et Digestive - Hôpital Beaujon - 100 boulevard du Général Leclerc Clichy, France, 92110 Centre d'Oncologie et Radiothérapie - rue du Dr Schweitzer La Rochelle, France, 17000 Service de Chirurgie Digestive - Hôpital A. Michallon - CHU de Grenoble - Boulevard de la Chantourne La Tronche, France, 38700 Département de Chirurgie Oncologique - Centre Oscar Lambret - 3 rue Combemale Lille, France, 59020 Service de Chirurgie Générale - Hôpitaux Civils de Lyon Lyon, France, 69317 Département de Chirurgie Oncologique - Centre Léon Bérard - 28 rue Laennec Lyon, France, 69373 Institut Paoli Calmette Marseille, France, 13009 Service de Chirurgie Digestive et viscérale - CHU Timone - 264 rue Saint Pierre Marseille, France, 13385 Département de Chirurgie Oncologique - CRLC Val d'Aurelle Montpellier, France, 34298 CHU Nantes Nantes, France, 44000 Service d'Oncologie-Radiothérapie - Centre antoine Lacassagne - 33 avenue de Valombrose Nice, France, 06189 Service de Chirurgie Générale - Hôpital Archet II Nice, France, 06202 CHU Nîmes Nîmes, France, 30029 Département Médico-Chirurgical de Pathologie Digestive - Hôpital Lariboisière - 2 rue Ambroise Paré Paris, France, 75010 Service de Cancérologie - Radiothérapie - Hôpital Saint-Louis - 1 avenue Claude Vellefeaux Paris, France, 75010 Service de Chirurgie Digestive - Hôpital des Diaconnesses - la Croix Saint-Simon - 125 rue d'Avron Paris, France, 75010 Service de Chirurgie Générale et Digestive - Hôpital Saint-Antoine - 184 rue du Faubourg Saint-Antoine Paris, France, 75012 Service d'Oncologie - Radiothérapie - Hôpital Tenon - 4 rue de la Chine Paris, France, 75970 Service de Radiothérapie - Oncologie - Centre Hospitalier Lyon Sud - Hôpitaux Civils de Lyon - 165 chemin du Grand Revoyet Pierre Benite, France, 69495 Service de Chirurgie Viscérale - CHU pontchaillou - 2 rue Henri Le Guilloux Rennes, France, 35033 Département des Radiations - Centre Eugène Marquis - rue de la Bataille Flandres-Dunkerque Rennes, France, 35042 Service de Chirurgie Digestive - CHU Charles Nicolle - 1 rue Germont Rouen, France, 76031 Service de Radiothérapie-Oncologie - centre Henri Becquerel - rue d'Amiens Rouen, France, 76038 Service de Chirurgie Oncologique - Centre René Gauducheau - Boulevard Jacques Monod Saint Herblain, France, 44805 Service de Chirurgie Viscérale - Clinique Charcot - 51-52 rue Commandant Charcot Sainte Foy les Lyon, France, 69110 Département de Radiothérapie - Centre Paul Strauss - 3 rue de la Porte de l'Hôpital Strasbourg, France, 67065 Service de Chirurgie Digestive - Hôpital Hautepierre Strasbourg, France, 67200 Département d'Oncologie Médicale - Institut Claudius Régaud - 20-24 rue du Pont Saint Pierre Toulouse, France, 31052 Service de Chirurgie Digestive - Hôpital Purpan - Place du Docteur Baylac Toulouse, France, 31059 Département de Chirurgie Oncologique - Centre Alexis Vautrin - Avenue de Bourgogne Vandoeuvre les Nancy, France, 54511 Service de Chirurgie Digestive et Générale - CHU Brabois - avenue de Bourgogne Vandoeuvre les Nancy, France, 54511 Less <<
NCT00939003 - Completed - -
NCT01362933 - Completed - -
NCT01352845 - Completed - -
NCT01211652 - Completed - -
NCT01420055 Multiple Sclerosis, Relapsing-... More >>Remitting Less << Phase 4 Completed - France ... More >> Novartis Investigative Site Agen Cedex 9, France, 47923 Novartis Investigative Site Amiens Cedex 1, France, 80054 Novartis Investigative Site Angers Cedex 1, France, 49033 Novartis Investigative Site Auxerre, France, 89000 Novartis Investigative Site Avignon, France, 84000 Novartis Investigative Site Bayonne, France, 64109 Novartis Investigative Site Beziers, France, 34525 Novartis Investigative Site Bobigny Cedex, France, 93009 Novartis Investigative Site Brest, France, 29240 Novartis Investigative Site Calais, France, 62107 Novartis Investigative Site Castelnau-le-Lez, France, 34170 Novartis Investigative Site Chambray les Tours, France, 37175 Novartis Investigative Site Cherbourg, France, 50100 Novartis Investigative Site Clermont-Ferrand Cedex 1, France, 63003 Novartis Investigative Site Créteil, France, 94010 Novartis Investigative Site Dijon, France, 21034 Novartis Investigative Site Epinal, France, 88021 Novartis Investigative Site Grenoble Cedex 9, France, 38042 Novartis Investigative Site Hagueneau, France, 67500 Novartis Investigative Site La Rochelle cedex 1, France, 17019 Novartis Investigative Site La Seyne sur mer, France, 83500 Novartis Investigative Site Le Kremlin Bicetre, France, 94275 Novartis Investigative Site Le Mans Cedex 09, France, 72037 Novartis Investigative Site Limoges, France Novartis Investigative Site Lyon, France, 69275 Novartis Investigative Site Marseille, France, 13008 Novartis Investigative Site Marseille, France, 13012 Novartis Investigative Site Metz, France, 57085 Novartis Investigative Site Montpellier, France, 34000 Novartis Investigative Site Montpellier, France, 34295 Novartis Investigative Site Nimes, France, 32900 Novartis Investigative Site Orsay, France, 91401 Novartis Investigative Site Paris, France, 75005 Novartis Investigative Site Poitiers, France, 86021 Novartis Investigative Site Pontoise, France, F-95300 Novartis Investigative Site Reims, France, 51092 Novartis Investigative Site Rennes Cedex, France, 35033 Novartis Investigative Site Roanne, France, 42328 Novartis Investigative Site Saint Aubin sur Scie, France, 76550 Novartis Investigative Site Saint Jean, France, 31243 Novartis Investigative Site Sainte Foy les Lyon, France, 69110 Novartis Investigative Site Saumur, France, 49400 Novartis Investigative Site Strasbourg Cedex, France, 67091 Novartis Investigative Site Talant, France, 21240 Novartis Investigative Site Toulouse, France, 31059 Novartis Investigative Site Tourcoing, France, 59200 Novartis Investigative Site Tours Cedex, France, 37044 Less <<
NCT00182481 Asthma Not Applicable Completed - Canada, Ontario ... More >> Firestone Institute for Respiratory Health, St. Joseph's Healthcare Hamilton, Ontario, Canada, L8N 4A6 Less <<
NCT00925470 - Completed - -
NCT01756612 - Completed - -
NCT01977573 Anaemia Phase 2 Completed - -
NCT01352845 Healthy Phase 3 Completed - -
NCT01896232 Secondary Hyperparathyroidism ... More >> Chronic Kidney Disease Less << Phase 3 Completed - -
NCT01712217 Non-small Cell Lung Cancer(NSC... More >>LC) Less << Phase 1 Phase 2 Completed - -
NCT02505750 Rectal Neoplasms Phase 3 Recruiting September 2022 Denmark ... More >> Aarhus University Hospital Not yet recruiting Aarhus, Denmark, 8000 Principal Investigator: Karen-Lise GARM-SPINDLER, MD          Sub-Investigator: Soren LAURBERG, MD          France Hospices Civils de Lyon - Hôpital de la Croix Rousse Not yet recruiting Lyon, France, 69004 Principal Investigator: Jean-Yves MABRUT, MD          Centre Léon Bérard Not yet recruiting Lyon, France, 69008 Principal Investigator: Christian CARRIE, MD          Sub-Investigator: Pascal POMMIER, MD          Sub-Investigator: Isabelle MARTEL-LAFAY, MD          Hôpital La Timone - AP-HM Not yet recruiting Marseille, France, 13005 Principal Investigator: Didier COWEN, Prof          Institut Paoli Calmette Not yet recruiting Marseille, France, 13009 Principal Investigator: Michel RESBEUT, MD          Sub-Investigator: Laurence MOUREAU-ZABOTTO, MD          Centre Azuréen de Cancérologie Not yet recruiting Mougins, France, 06250 Principal Investigator: Eric TEISSIER, MD          Centre d'oncologie et de radiothérapie Mâcon Not yet recruiting Mâcon, France, 71000 Principal Investigator: Nicolas BARBET, MD          Centre de Haute Energie Not yet recruiting Nice, France, 06000 Principal Investigator: Michel MORO, MD          Sub-Investigator: Olivier THOMAS, MD          Sub-Investigator: René-Jean BENSADOUN, Prof          Centre Antoine Lacassagne Recruiting Nice, France, 06189 Contact: Jean-Pierre GERARD, Prof    +33 492031260    jean-pierre.gerard@nice.unicancer.fr    Principal Investigator: Jean-Pierre GERARD, Prof          Sub-Investigator: Karen BENEZERY, MD          Sub-Investigator: Jérôme DOYEN, MD          Sub-Investigator: Eric FRANCOIS, MD          Hospices Civils de Lyon - Centre Hospitalier Lyon-Sud Not yet recruiting Pierre Bénite, France, 69495 Principal Investigator: Patrice LORCHEL, MD          Sub-Investigator: Olivier CHAPET, MD          Institut de Cancérologie Lucien Neuwirth Not yet recruiting Saint-Priest en Jarez, France, 42270 Principal Investigator: Guy DE LAROCHE, MD          Sub-Investigator: Nicolas MAGNE, Prof          Clinique Charcot Not yet recruiting Sainte Foy-Lès-Lyon, France, 69110 Principal Investigator: Pascale ROMESTAING, MD          Sub-Investigator: Marc PAPILLON, MD          Sub-Investigator: Philippe CANAT, MD          Hôpital de la Croix Rouge Française - Centre de Radiothérapie St Louis Not yet recruiting Toulon, France, 83100 Principal Investigator: Thomas DUBERGE, MD          Centre de radiothérapie Bayard Not yet recruiting Villeurbanne, France, 69100 Principal Investigator: Régis COQUARD, MD          Sub-Investigator: Nicolas BARBET, MD          Sweden Karolinska Institute Not yet recruiting Stockolm, Sweden, 16 S-11330 Principal Investigator: Anna MARTLING, MD          University of Uppsala Not yet recruiting Uppsala, Sweden, 753 13 Principal Investigator: Calin RADU, MD          Sub-Investigator: Joakim FOLKESSON, MD          United Kingdom Royal Surrey County Hospital Not yet recruiting Guildford, United Kingdom, GU2 7XX Principal Investigator: Alexandra STEWART, MD          Spire Hull and East Riding Hospital Not yet recruiting Hull, United Kingdom, HU10 7AZ Principal Investigator: Amandeep DHADDA, MD          Clatterbridge Cancer Centre NHS Foundation Trust Not yet recruiting Liverpool, United Kingdom, L9 7BA Principal Investigator: Arthur SUN MYINT, Prof          University Hospital Not yet recruiting Nottingham, United Kingdom, NG5 8RX Principal Investigator: Jamie MILLS, MD Less <<
NCT00150371 Hypercholesterolemia Phase 3 Completed - -
NCT01777074 - Completed - -
NCT00729235 Biventricular Tachycardias Phase 4 Completed - -
NCT00244842 Psoriasis Phase 3 Completed - Canada, Alberta ... More >> Isotechnika Investigational Site Calgary, Alberta, Canada, T2S 3B3 Isotechnika Investigational Site` Edmonton, Alberta, Canada, T5J 3S9 Isotechnika Investigational Site Edmonton, Alberta, Canada, T5J 3S9 Canada, British Columbia Isotechnika Investigational Site Vancouver, British Columbia, Canada, V5Z 3Y1 Isotechnika Investigational Site Vancouver, British Columbia, Canada, V5Z 4E8 Isotechnika Investigational Site Victoria, British Columbia, Canada, V8R 6V4 Canada, Manitoba Isotechnika Investigational Site Winnipeg, Manitoba, Canada, R3C 0N2 Canada, New Brunswick Isotechnika Investigational Site Moncton, New Brunswick, Canada, E1C 8X3 Canada, Newfoundland and Labrador Isotechnika Investigational Site St. John's, Newfoundland and Labrador, Canada, A1B 3E1 Isotechnika Investigational Site St. John's, Newfoundland and Labrador, Canada, A1B 4F8 Canada, Nova Scotia Isotechnika Investigational Site Halifax, Nova Scotia, Canada, B3H 1Z4 Canada, Ontario Isotechnika Investigational Site Hamilton, Ontario, Canada, L8N 1V6 Isotechnika Investigational Site London, Ontario, Canada, N5X 2P1 Isotechnika Investigational Site London, Ontario, Canada, N6A 3H7 Isotechnika Investigational Site Maple, Ontario, Canada, L4K 5V2 Isotechnika Investigational Site Markham, Ontario, Canada, L3P 1A8 Isotechnika Investigational Site Newmarket, Ontario, Canada, L3Y 6P5 Isotechnika Investigational Site North Bay, Ontario, Canada, L4M 6L2 Isotechnika Investigational Site North Bay, Ontario, Canada, P1B 3Z7 Isotechnika Investigational Site Oakville, Ontario, Canada, L6K 1E1 Isotechnika Investigational Site Oshawa, Ontario, Canada, L1H 1B9 Isotechnika Investigational Site Toronto, Ontario, Canada, M5V 2T3 Isotechnika Investigational Site Waterloo, Ontario, Canada, N2J 1C4 Isotechnika Investigational Site Windsor, Ontario, Canada, N8W 1E6 Isotechnika Investigational Site Windsor, Ontario, Canada, N8W 5L7 Canada, Quebec Isotechnika Investigational Site Laval, Quebec, Canada, H7G 2C0 Isotechnika Investigational Site Montreal, Quebec, Canada, H2K 4L5 Isotechnika Investigational Site Montreal, Quebec, Canada, H3G 1C6 Isotechnika Investigational Site Pointe Claire, Quebec, Canada, H9R 4S3 Isotechnika Investigational Site Sherbrooke, Quebec, Canada, J1J 2B8 Isotechnika Investigational Site Ste. Foy, Quebec, Canada, G1V 4X7 Less <<
NCT01977573 - Completed - -
NCT02286362 - Completed - -
NCT02945722 Hemodialysis Patients Phase 4 Recruiting November 30, 2020 France ... More >> CH d'Annecy-Genevois Not yet recruiting Annecy, France Principal Investigator: Benoît FRANKO, MD          Ch Annonay Not yet recruiting Annonay, France Principal Investigator: Carole DEPRELE, MD          Ch Cannes Not yet recruiting Cannes, France Principal Investigator: Manuela DODOI, MD          AGDUC Not yet recruiting La Tronche, France Principal Investigator: Nadège MINGAT, MD          CH Emile Roux Not yet recruiting Le Puy-en-Velay, France Principal Investigator: Marc BOUILLER, MD          Sub-Investigator: Viorica BARBU, MD          Aural Not yet recruiting Lyon, France Principal Investigator: Jean-Christophe SZELAG, MD          CH St-Joseph St-Luc Not yet recruiting Lyon, France Principal Investigator: Cécile CHAUVET, MD          CHU Lyon Not yet recruiting Lyon, France Principal Investigator: Laurent JUILLARD, MD          AIDER Santé Not yet recruiting Montpellier, France Principal Investigator: Nathalie RAYNAL, MD          Sub-Investigator: Cécile GUIRAUD, MD          CH Roanne Not yet recruiting Roanne, France Principal Investigator: Aurore SURY, MD          ARTIC42 Recruiting Saint Etienne, France Principal Investigator: Jacques JURINE, MD          Sub-Investigator: Aida AFIANI, MD          Sub-Investigator: Linda AZZOUZ, MD          Sub-Investigator: Aline CHABROUX-SEFFERT, MD          Chu Saint-Etienne Recruiting Saint-etienne, France Principal Investigator: Elisabeth BOTHELO-NEVERS, MD          Sub-Investigator: Amandine GAGNEUX-BRUNON, MD          Sub-Investigator: Fréderic LUCHT, MD          Sub-Investigator: Philippe BERTHELOT, MD          Sub-Investigator: Florence GRATTARD, MD          Sub-Investigator: Paul VERHOEVEN, MD          Sub-Investigator: Anne CARRICAJO, MD          Sub-Investigator: Damien THIBAUDIN, MD          Sub-Investigator: Eric ALAMARTINE, MD          Sub-Investigator: Christophe MARIAT, MD          Sub-Investigator: Hesham MOHEY, MD          NephroCare Not yet recruiting Sainte-foy-les-Lyon, France Principal Investigator: Manolie MEHDI, MD Less <<
NCT03386682 Breast Augmentation ... More >> Breast Reconstruction Less << Not Applicable Recruiting December 2020 France ... More >> Centre F.X. Michelet Chu Bordeaux Recruiting Bordeaux, France, 33076 Contact: VINCENT CASOLI, MD, PhD          Chu Pasteur Recruiting Nice, France, 06000 Contact: Bérengère Chignon-Sicard, MD          Clinique des Champs Elysées Recruiting Paris, France, 75008 Contact: Nicolas MOTTIER, MD          Clinique BIZET Recruiting Paris, France, 75016 Contact: Isabelle SARFATI (Co-PI), MD          Institut du Sein Recruiting Paris, France, 75017 Contact: Isabelle SARFATI, MD          Hopital Tenon Recruiting Paris, France, 75020 Contact: MICHAEL ATLAN, MD          Clinique Charcot Recruiting Sainte-Foy-lès-Lyon, France, 69500 Contact: EMMANUEL DELAY, MD          Institut Gustave Roussy Recruiting Villejuif, France, 94805 Contact: Françoise RIMAREIX, MD Less <<
NCT01896232 - Completed - -
NCT00163514 Perennial Allergic Rhinitis ... More >> Allergic Rhinitis Hay Fever Less << Phase 3 Completed - -
NCT02886962 Kidney Failure, Chronic Phase 4 Recruiting January 2023 France ... More >> Service de Néphrologie et médecine interne Not yet recruiting Amiens, France, 80000 Contact: Gabriel CHOUKROUN, MD          CHRU d'Angers - Service de Néphrologie Not yet recruiting Angers, France, 49033 Contact: Virginie Besson, MD          Service Néphrologie, Dialyse, Transplantation Not yet recruiting Caen, France, 14033 Contact: Patrick HENRI, MD          Pathologie Rénale Recruiting Chambéry, France, 73000 Contact: Laure Croze, MD    0479965084       Service de Néphrologie Not yet recruiting Cherbourg-Octeville, France, 50102 Contact: Guillaume QUEFFEULOU, MD          Aural Colmar Recruiting Colmar, France, 68000 Contact: Claire BORNI DUVAL, MD       c.borni-duval@aural.asso.fr    Service de néphrologie Not yet recruiting Colmar, France, 68000 Contact: Alexandre KLEIN, MD          Service de néphrologie Not yet recruiting Dijon, France, 21000 Contact: Emmanuelle KOHLER, MD          Aurad Aquitaine Not yet recruiting Gradignan, France, 33170 Contact: Catherine LASSEUR, MD          Centre Hospitalier de Haguenau - service de Néphrologie Not yet recruiting Haguenau, France, 67504 Contact: Yves DIMITROV, MD          AURAL Haguenau Not yet recruiting Haguenau, France Contact: Yves DIMITROV       yves.dimitrov@ch-haguenau.fr    Centre Hospitalier Emile Roux Not yet recruiting Le Puy-en-Velay, France, 43000 Contact: Marc BOUILLER       marc.bouiller@ch-lepuy.fr    Clinique Bouchard Recruiting Marseille, France, 13006 Contact: Jérome SAMPOL, MD          Service de Néphrologie Not yet recruiting Nancy, France, 54511 Contact: Luc Frimat, MD          ECHO de Nantes Recruiting Nantes, France, 44000 Contact: Angelo TESTA, MD          Service de Néphrologie Not yet recruiting Nantes, France, 44093 Contact: Frédéric LAVAINNE, MD          AURA Paris Plaisance Not yet recruiting Paris, France, 75014 Contact: Maxime TOUZOT, MD          Hôpital Tenon - Service de Néphrologie Recruiting Paris, France, 75970 Contact: Hafedh FESSI, MD          Service de néphrologie Recruiting Rennes, France, 35033 Contact: Cécile VIGNEAU, MD          ECHO CA Laennec Not yet recruiting Saint-Herblain, France, 44821 Contact: Dan HRISTEA, MD          NéphroCare Tassin-Charcot Not yet recruiting Sainte-Foy-lès-Lyon, France, 69110 Contact: Guillaume JEAN, MD          AURAL st Anne Recruiting Strasbourg, France, 67000 Contact: Clotilde MULLER       Clotilde-muller@hotmail.fr    Service de Néphrologie Recruiting Strasbourg, France, 67000 Contact: Thierry Hannedouche, MD          Centre Hospitalier Bretagne-Atlantique Not yet recruiting Vannes, France, 56017 Contact: Pierre Yves DURAND, MD          Calydial CH Lucien Hussel Not yet recruiting Vienne, France, 38209 Contact: Agnès CAILLETTE BEAUDOIN, MD Less <<
NCT00706849 Heterozygous Familial Hypercho... More >>lesterolemia Coronary Artery Disease Less << Phase 3 Completed - -
NCT00658515 Coronary Heart Disease Phase 3 Completed - -
NCT00706849 - Completed - -
NCT01059682 Cardiovascular Disease Phase 3 Terminated(Termination of the ... More >>clinical development program by the Sponsor) Less << - -
NCT01042769 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT00827606 Familial Hypercholesterolemia Phase 3 Completed - -
NCT00035464 Atrial Fibrillation Phase 3 Completed - -
NCT00827606 - Completed - -
NCT00034840 Hypertension Phase 4 Completed - -
NCT00035477 Atrial Fibrillation Phase 3 Completed - -
NCT00004978 - Completed - -
NCT02042898 Disorder; Heart, Functional, P... More >>ostoperative, Cardiac Surgery Less << Not Applicable Completed - -
NCT00035971 Osteoporosis Phase 4 Completed - -
NCT00004978 HIV Infections Phase 3 Completed - -
NCT00043927 Small Cell Lung Cancer Phase 3 Completed - -
NCT00044577 Human Immunodeficiency Virus I... More >> Infection HIV Infection Less << Phase 3 Completed - -
NCT01266876 Hypercholesterolemia Phase 2 Completed - -
NCT00049998 Non-Small-Cell Lung Cancer Phase 3 Completed - -
NCT01266876 - Completed - -
NCT00002995 Sarcoma Phase 3 Completed - -
NCT00002594 Brain Tumor C... More >>entral Nervous System Tumor Less << Phase 2 Completed - -
NCT00044343 Colorectal Cancer Phase 2 Completed - -
NCT00003119 Neuroblastoma Phase 3 Completed - -
NCT00050609 Gastroparesis Phase 2 Completed - Canada, Alberta ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Edmonton, Alberta, Canada Canada, British Columbia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vancouver, British Columbia, Canada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Victoria, British Columbia, Canada Canada, Manitoba For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Winnipeg, Manitoba, Canada Canada, Ontario For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Courtice, Ontario, Canada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamilton, Ontario, Canada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kitchener, Ontario, Canada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. London, Ontario, Canada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ottawa, Ontario, Canada Canada, Quebec For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Montreal, Quebec, Canada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sainte-Foy, Quebec, Canada Canada, Saskatchewan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saskatoon, Saskatchewan, Canada Less <<
NCT00003593 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 3 Completed - -
NCT00003955 Sarcoma Phase 2 Completed - -
NCT00003093 Neuroblastoma Phase 3 Completed - -
NCT00005596 Leukemia Phase 3 Completed - -
NCT00047437 Cardiovascular Diseases ... More >> Heart Diseases Heart Failure, Congestive Less << Phase 3 Completed - -
NCT00021242 Leukemia Phase 2 Completed - -
NCT00006462 Leukemia Phase 2 Completed - -
NCT00028795 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - -
NCT00056069 Leukemia Not Applicable Completed - -
NCT00057317 Diabetes Phase 2 Completed - -
NCT00056446 Colorectal Neoplasms ... More >> Colonic Neoplasms Rectal Neoplasms Less << Phase 3 Completed - -
NCT00006102 Brain and Central Nervous Syst... More >>em Tumors Lymphoma Neuroblastoma Retinoblastoma Sarcoma Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 2 Completed - -
NCT00065182 Non-Small-Cell Lung Cancer ... More >> Lung Cancer, Non-Small Cell Less << Phase 2 Completed - -
NCT00071279 Pulmonary Embolism ... More >> Deep Vein Thrombosis Less << Phase 3 Completed - -
NCT01753180 Chronic Coronary Total Occlusi... More >>ons Less << Phase 2 Completed - Canada, Alberta ... More >> Foothills Medical Centre Calgary, Alberta, Canada, T2N 4Z6 Canada, Manitoba St. Boniface Hospital Winnipeg, Manitoba, Canada, R2H 2A6 Canada, Ontario Hamilton Health Sciences Hamilton, Ontario, Canada, L8L 2X2 London Health Sciences Centre London, Ontario, Canada, N6A 5A5 University of Ottawa Heart Institute Ottawa, Ontario, Canada, K1Y 4W7 Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Canada, Quebec CHUM Hotel Dieu Montreal, Quebec, Canada, H2W 1T8 Hopital du Sacre-Coeur de Montreal Montreal, Quebec, Canada, H4J 1C5 Centre de recherche de l'Institut Universitaire de Pulmonologie et Cardiologie de Quebec Ste. Foy, Quebec, Canada, G1V 4G5 Israel Shaare Zedek Medical Center Jerusalem, Israel, 91031 Netherlands Academic Medical Center Amsterdam, Netherlands, 1105 AZ Less <<
NCT00003811 Childhood Germ Cell Tumor ... More >> Drug/Agent Toxicity by Tissue/Organ Extragonadal Germ Cell Tumor Ovarian Cancer Less << Phase 2 Completed - -
NCT00056459 Colorectal Neoplasms ... More >> Colonic Neoplasms Rectal Neoplasms Less << Phase 3 Completed - -
NCT00003573 Brain Tumors ... More >>Central Nervous System Tumors Less << Phase 2 Completed - -
NCT00003937 Cardiac Toxicity ... More >> Sarcoma Less << Phase 3 Completed - -
NCT00003935 Brain Tumors ... More >>Central Nervous System Tumors Less << Phase 1 Completed - -
NCT00003783 Leukemia Phase 2 Completed - -
NCT01196039 Asthma Phase 2 Completed - Canada, Alberta ... More >> Calgary, Alberta, Canada, T2N 4Z6 Edmonton, Alberta, Canada, T6G1Z1 Canada, British Columbia Vancouver, British Columbia, Canada, V5Z 1M9 Canada, Ontario Hamilton, Ontario, Canada, L8N 3Z5 Canada, Quebec Ste. Foy, Quebec, Canada, G1V 4G5 Canada, Saskatchewan Saskatoon, Saskatchewan, Canada, S7N 0W8 Sweden Stockholm, Sweden, S-14186 Less <<
NCT00004852 HIV Infections Phase 2 Completed - -
NCT01872689 Idiopathic Pulmonary Fibrosis Phase 2 Completed - -
NCT00005663 Herpes Simplex ... More >> HIV Infections Herpes Genitalis Less << Phase 3 Unknown - -
NCT00006208 HIV Infections Phase 3 Unknown - -
NCT00087711 Non Small Cell Lung Carcinoma Phase 3 Completed - -
NCT00088803 - Completed - -
NCT00003625 Brain Tumors ... More >>Central Nervous System Tumors Less << Phase 1 Completed - -
NCT00089986 - Completed - -
NCT00003671 Leukemia Phase 2 Completed - -
NCT00091637 Acute Myocardial Infarction Phase 3 Completed - -
NCT01872689 - Completed - -
NCT00095199 Non Small Cell Lung Cancer Phase 3 Completed - -
NCT00089986 Sepsis Phase 2 Completed - -
NCT00091715 Pulmonary Hypertension Phase 3 Completed - -
NCT00005585 Leukemia Phase 3 Completed - -
NCT00095199 - Completed - -
NCT00098293 HIV-1 Phase 3 Completed - -
NCT01789957 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00035490 Arrhythmia Phase 3 Completed - -
NCT00098293 - Completed - -
NCT00036647 Carcinoma, Non-small-cell Lung Phase 3 Completed - -
NCT00101985 Irritable Colon Phase 2 Completed - -
NCT00038454 Cardiovascular Disease Phase 2 Phase 3 Suspended - -
NCT00102778 Infection, Human Immunodeficie... More >>ncy Virus I HIV Infection Less << Phase 2 Terminated - -
NCT00106509 Clostridium Enterocolitis ... More >> Pseudomembranous Colitis Less << Phase 3 Completed - -
NCT00035347 Community-Acquired Pneumonia (... More >>CAP) Less << Phase 4 Completed - -
NCT00106548 Rheumatoid Arthritis Phase 3 Completed - -
NCT00040183 Pancreatic Cancer Phase 3 Completed - -
NCT00113308 Arthritis, Rheumatoid Phase 3 Completed - -
NCT00111800 - Completed - -
NCT00125346 Cystic Fibrosis Phase 3 Terminated(per Data Monitoring... More >> Committee recommendation) Less << - -
NCT00123734 Deep Vein Thrombosis Phase 2 Completed - United States, California ... More >> UC Davis Sacramento, California, United States, 95817 UCSD Medical Centre San Diego, California, United States, 82103-9378 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Oklahoma University of Oklahoma, Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 Canada, Ontario Hamilton General Hospital Hamilton, Ontario, Canada, L8L 2X2 McMaster University, Hamilton Health Sciences Hamilton, Ontario, Canada, L8N 3Z5 St. Joseph's Healthcare Hamilton, Ontario, Canada, L8N4A6 Henderson General Site Hamilton, Ontario, Canada, L8V1C3 Canada, Quebec Hopital Maisonneuve-Rosemont Montreal, Quebec, Canada, H1T 2M4 Hotel-Dieu Du CHUM Montreal, Quebec, Canada, H2W1T8 Centre hospitalier de L'Universite Laval Sainte-Foy, Quebec, Canada, G1V 4G2 Less <<
NCT00123734 - Completed - -
NCT00097825 Osteoporosis Phase 3 Completed - -
NCT00051636 - Completed - -
NCT00111800 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT00003793 - Completed - -
NCT00003833 - Completed - -
NCT00051636 Paget's Disease of Bone Phase 3 Completed - -
NCT00137332 Arrhythmia Phase 2 Terminated - -
NCT00004188 Neuroblastoma Phase 3 Completed - -
NCT00003857 Breast Cancer Phase 3 Active, not recruiting February 2023 -
NCT00006760 Lymphoma Phase 2 Completed - -
NCT00022191 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Urethral Cancer Less << Phase 3 Completed - -
NCT00028899 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 1 Completed - -
NCT00053352 Childhood Embryonal Tumor ... More >> Childhood Extracranial Germ Cell Tumor Childhood Extragonadal Germ Cell Tumor Childhood Malignant Ovarian Germ Cell Tumor Childhood Malignant Testicular Germ Cell Tumor Childhood Teratoma Ovarian Embryonal Carcinoma Ovarian Yolk Sac Tumor Stage II Malignant Testicular Germ Cell Tumor Stage IIA Ovarian Germ Cell Tumor Stage IIB Ovarian Germ Cell Tumor Stage IIC Ovarian Germ Cell Tumor Stage III Malignant Testicular Germ Cell Tumor Stage IIIA Ovarian Germ Cell Tumor Stage IIIB Ovarian Germ Cell Tumor Stage IIIC Ovarian Germ Cell Tumor Testicular Choriocarcinoma and Yolk Sac Tumor Testicular Embryonal Carcinoma Less << Phase 3 Completed - -
NCT00053352 - Completed - -
NCT00026338 Pancreatic Cancer Phase 3 Completed - -
NCT00144911 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 4 Completed - -
NCT00030641 Lung Cancer Phase 2 Phase 3 Unknown - -
NCT00152386 Rheumatoid Arthritis Phase 3 Completed - -
NCT00157339 Diabetes Mellitus ... More >> Asthma Pulmonary Disease, Chronic Obstructive Less << Phase 3 Completed - -
NCT00149981 Organ Transplantation Phase 4 Completed - -
NCT00168844 Pulmonary Disease, Chronic Obs... More >>tructive Less << Phase 3 Completed - -
NCT00157014 - Completed - -
NCT00157014 Heart Diseases ... More >> Heart Transplantation Less << Phase 3 Completed - United States, California ... More >> Los Angeles, California, United States, 90095 Canada, Alberta Calgary, Alberta, Canada, T2N 2T9 Edmonton, Alberta, Canada, T6G 2B7 Edmonton, Alberta, Canada, T6G 2E1 Canada, British Columbia Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Nova Scotia Halifax, Nova Scotia, Canada, B3H 3A7 Canada, Ontario London, Ontario, Canada, N6A 5A5 Ottawa, Ontario, Canada, K1Y 4W7 Toronto, Ontario, Canada, M5G 1X8 Toronto, Ontario, Canada, M5G 2N2 Canada, Quebec Montreal, Quebec, Canada, H1T 1C8 Montreal, Quebec, Canada, H3A 1A1 Sainte-Foy, Quebec, Canada, G1V 4G5 Less <<
NCT00169897 COPD Not Applicable Completed - Canada, British Columbia ... More >> St-Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Nova Scotia Halifax Infirmary Halifax, Nova Scotia, Canada, B3H 3A7 Canada, Quebec CRMSBC/Centre Hospitalier Baie-des-Chaleurs Bonaventure, Quebec, Canada, G0C 1YO Jewish Rehabilitation Hospital Laval, Quebec, Canada, H7V 1R2 Hopital Hotel-Dieu de Levis Levis, Quebec, Canada, G6V 3Z1 Montreal Chest Institute Montreal, Quebec, Canada, H2X 2P4 Hopital Sacre-Coeur Montreal, Quebec, Canada, H4J 1C5 Mount Sinai Hospital Montreal, Quebec, Canada, H4W 1S7 CHA Enfant Jesus Quebec City, Quebec, Canada, G1J 1Z4 Hopital Laval Sainte-Foy, Quebec, Canada, G1V 4G5 Less <<
NCT00172081 Osteoporosis Phase 3 Completed - -
NCT00168844 - Completed - -
NCT00175877 Rheumatoid Arthritis Phase 3 Completed - -
NCT00172133 Osteoporosis Phase 3 Completed - -
NCT00191113 Turner Syndrome Phase 3 Completed - Canada, Alberta ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Calgary, Alberta, Canada, T2T 5C7 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Edmonton, Alberta, Canada, T6G 2B7 Canada, British Columbia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vancouver, British Columbia, Canada, V6H 3V4 Canada, Manitoba For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Winnipeg, Manitoba, Canada, R3E 0Z2 Canada, Nova Scotia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Halifax, Nova Scotia, Canada, B3J 3G9 Canada, Ontario For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamilton, Ontario, Canada, L8S 3Z5 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kingston, Ontario, Canada, K7L 3N6 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. London, Ontario, Canada, K7L 3N6 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ottawa, Ontario, Canada, K1H 8L1 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toronto, Ontario, Canada, M5G 1X8 Canada, Quebec For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Montreal, Quebec, Canada, H3H 1P3 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Montreal, Quebec, Canada, H3T 1C5 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sainte-Foy, Quebec, Canada, G1V 4G2 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sherbrooke, Quebec, Canada, J1G 2E8 Less <<
NCT00169559 Dyslipidaemias Phase 2 Completed - -
NCT00175877 - Completed - -
NCT00224484 Herpes Simplex Phase 3 Completed - -
NCT00158860 Herpes Genitalis Phase 4 Completed - -
NCT00225277 Diabetes Mellitus Phase 3 Completed - -
NCT00191113 - Completed - -
NCT00198510 Vitreous Hemorrhage ... More >> Diabetic Retinopathy Less << Phase 3 Completed - -
NCT00231114 Asthma Not Applicable Completed - -
NCT00225277 - Completed - -
NCT00231114 - Completed - -
NCT00241553 NSAIDs Upper ... More >>GI Symptoms Less << Phase 3 Completed - -
NCT00239538 Hypertension ... More >>Diabetes Mellitus, Type 2 Less << Phase 4 Completed - -
NCT00242879 Infection, Human Immunodeficie... More >>ncy Virus I HIV-1 Infection Less << Phase 2 Terminated - -
NCT00241527 NSAIDs Upper ... More >>GI Symptoms Less << Phase 3 Completed - -
NCT00251992 Gastrointestinal Disease ... More >> Signs and Symptoms, Digestive Dyspepsia Less << Phase 3 Completed - -
NCT00247273 - Completed - -
NCT00224484 - Completed - -
NCT00002575 Colorectal Cancer Phase 3 Completed - -
NCT00264550 Rheumatoid Arthritis Phase 3 Completed - -
NCT00247273 Postmenopausal Osteoporosis Phase 3 Completed - -
NCT00241605 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT00265083 - Completed - -
NCT00264550 - Completed - -
NCT00266682 Bradycardia Not Applicable Completed - -
NCT00265083 Spondylitis, Ankylosing Phase 3 Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.40mL

0.48mL

0.24mL

11.98mL

2.40mL

1.20mL

23.95mL

4.79mL

2.40mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories